The Effects of Relaxation and Laughter on the Perceived Intensity and Affect of Pain Tolerance. by Davies, Simon
Louisiana State University
LSU Digital Commons
LSU Historical Dissertations and Theses Graduate School
1989
The Effects of Relaxation and Laughter on the
Perceived Intensity and Affect of Pain Tolerance.
Simon Davies
Louisiana State University and Agricultural & Mechanical College
Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_disstheses
This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion in
LSU Historical Dissertations and Theses by an authorized administrator of LSU Digital Commons. For more information, please contact
gradetd@lsu.edu.
Recommended Citation
Davies, Simon, "The Effects of Relaxation and Laughter on the Perceived Intensity and Affect of Pain Tolerance." (1989). LSU
Historical Dissertations and Theses. 4709.
https://digitalcommons.lsu.edu/gradschool_disstheses/4709
INFORMATION TO USERS
The most advanced technology has been used to photo­
graph and reproduce this manuscript from the microfilm 
master. UMI films the text directly from the original or 
copy submitted. Thus, some thesis and dissertation copies 
are in typewriter face, while others may be from any type 
of computer printer.
The quality of this reproduction is dependent upon the 
quality of the copy submitted. Broken or indistinct print, 
colored or poor quality illustrations and photographs, 
print bleedthrough, substandard margins, and improper 
alignment can adversely affect reproduction.
In the unlikely event that the author did not send UMI a 
complete manuscript and there are missing pages, these 
will be noted. Also, if  unauthorized copyright material 
had to be removed, a note will indicate the deletion.
Oversize materials (e.g., maps, drawings, charts) are re­
produced by sectioning the original, beginning at the 
upper left-hand corner and continuing from left to right in 
equal sections with small overlaps. Each original is also 
photographed in one exposure and is included in reduced 
form at the back of the book. These are also available as 
one exposure on a standard 35mm slide or as a 17" x 23" 
black and white photographic print for an additional 
charge.
Photographs included in the original manuscript have 
been reproduced xerographically in this copy. Higher 
quality 6" x 9" black and white photographic prints are 
available for any photographs or illustrations appearing 
in this copy for an additional charge. Contact UMI directly 
to order.
University Microfilms International 
A Bell & Howell Information Company 
300 North Zeeb Road, Ann Arbor, Ml 48106-1346 USA 
313/761-4700 800/521-0600

Order N um ber 9002136
The effects o f  relaxation and laughter on the perceived intensity  
and affect o f pain tolerance
Davies, Simon, Ph.D.
The Louisiana State University and Agricultural and Mechanical Col., 1989
UMI
300 N. Zeeb Rd.
Ann Arbor, MI 48106

THE EFFECTS OF RELAXATION AND LAUGHTER ON THE 
PERCEIVED INTENSITY AND AFFECT OF PAIN TOLERANCE
A Dissertation 
Submitted to the Graduate Faculty of the 
Louisiana State University and 
Agricultural and Mechanical College 
in partial fulfilment of the 
requirements for the degree of 
Doctor of Philosophy 
in
The School of Health, Physical Education, 
Recreation and Dance
by
Simon Davies
B. A. Hons. Birmingham University, England, 1978 
M. H. K. Windsor University, Canada, 1983 
M. A. Louisiana State University, 1988
May 1989
ACKNOWLEDGEMENTS
This dissertation is dedicated to my beautiful wife 
Anne, whose love and patience guided me through the 
"plateau of despond" on numerous occasions. Stubborn 
though I am, she has shown me new ways to be strong, I 
can at last see the light. To my parents, Esme and John 
Davies, I owe a special debt of gratitude. Their 
unfailing love and support has been one of the few 
constants in my life. They will always be shining 
examples to me. To my sisters and brother, and all 
extended family members, I offer thanks for being there. 
Friends from today and yesteryear, I thank you for your 
friendship. To my teachers, especially JPK, I thank you 
for providing the spark of intellectual curiosity. I 
would like to thank those professors who were helpful 
when they could have been distant, especially Mike 
Mangum, Richard Lomax, and Gary Gintner. I appreciate 
the assistance of my committee, especially Dr. Amelia 
Lee, and thank them for coming on board at such late 
notice! I would like to say thank you to some of the 
wonderful people we laughed and cried with in Baton 
Rouge, in particular Craig and Ronnie (eh!), Tom ("big 
guy") and Kris, Cos and Franko (coffee!), Bob Wood, Ken 
and Laura, Mike and Sue Mangum, Patti, and Sherry (I
ii
never would have graduated without your secretarial 
skills "par excellence" and warm heart). To my late 
furry friend "fat face", thank you for being warm and 
cuddly, I miss you.
I would also like to dedicate this dissertation to the 
memory of my dear Auntie Connie, a radiant soul.
FOREWORD
This manuscript is written in the format of the American 
Psychological Association. The body of the 
paper is presented in the format of submission for 
publication to scholarly journals. Additional 
information concerning measurement instruments and 
procedures, statistical procedures, tables, and 
literature studies reviewed for this research study are 
presented in the appendices.
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ABSTRACT
This study described the effect of relaxation and 
laughter on the perceived intensity and affect of pain 
induced by a cold water pressor test. Equal numbers of 
female athletic and non-athletic subjects (N = 36) were 
selected from varsity athletes and undergraduates at 
Louisiana State University. All subjects were 
pre-tested on their tolerance to a cold water pressor 
test. Responses on visual analogue scales for perceived 
pain intensity (I) and affect (A), and submersion time 
were recorded. The volunteer subjects were randomly 
assigned to one of three groups: relaxation-inducing, 
laughter-inducing, or control. Following a 20 minute 
exposure to the audio treatment tapes (laughter or 
relaxation), the subjects were measured again on their 
perceived tolerance to pain and submersion time. 
Subject's confidence in their level of tolerance were 
measured pre and post-treatment, and the expectancy of 
the efficacy of the treatment to increase perceived 
tolerance was also recorded post-treatment. Perceived 
pain (I and A), anxiety (STAI), confidence (CV and CS), 
relaxation (RE), and expctancy (EXPECT), were recorded 
pretest and posttest. Heart rate was monitored 
continuously using a photoelectric finger sensor. A 
multivariate mixed model (MMM) repeated measures was
xi
selected for the study. Correlational analyses were 
used to examine relationships between variables. 
Non-athletes were found to have lower perceived pain 
tolerance than athletes at pretest and posttest. Humor 
and relaxation treatments when combined significantly 
reduced both the perceived intensity (I) and affect (A) 
of pain. Follow-up ANOVAs revealed a significant time 
effect for anxiety (STAI), confidence (CS and CV), re­
laxation (RE), and heart rate (C and CH), across groups 
and treatments. Athletes were superior to non-athletes 
on perceived pain (I and A), submersion time, and confi­
dence (CV and CS). Further research is still needed on 
the relationship between humor and pain tolerance.
Effects of Laughter and Relaxation on Pain Tolerance
The Effects of Relaxation and Laughter on the 
Perceived Intensity and Affect of Pain Tolerance
In the field of athletics, Ryan and Kovacic (1966) 
suggest that social learning influences pain tolerance 
and is responsible for gender differences. Rosillo and 
Fogel (1973) claim that individuals become socialized 
into tolerating higher levels of pain. In their study, 
females with low pain tolerance reported less anxiety, 
depression and hostility than females with high pain 
tolerance. The opposite findings were obtained with 
male subjects.
Davies and Hall (1987) found that female non-athletes 
perceived pain induced by a cold water pressor test to 
be significantly higher than their athletic counterparts 
in both affect and intensity. According to Elton, 
Stanley and Burrows (1983), pain has evolved into a very 
complex, multi-level, interacting explanatory system, 
involving neurological, biochemical, personality and 
psychosocial variables. Accepting that pain does not 
appear to be experienced in only one dimension, several 
researchers have suggested that the experience of pain 
sensations is not necessarily accompanied by affective
1
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feelings of being hurt (Beecher, 1959; Meichenbaum,
1977; Stevens & Heide, 1977). Gracely, Dubner and 
McGrath (1979) have demonstrated that the intensity and 
unpleasantness dimensions of pain can be assessed 
separately and can thus be affected differentially by 
treatments.
The findings of Davies and Hall (1987) generally 
supported the contention that female athletes indicate 
lower levels of perceived intensity and affect of pain, 
as compared to their non-athletic counterparts. Thus, 
working within the parameter of existing differences 
between female athletes and non-athletes in pain 
tolerance, this present study attempted to discover 
whether existing levels of pain tolerance could be 
affected by different cognitive-behavioral methods. Past 
research (Boby & Davidson, 1976; Cogan, 1978; Cogan & 
Kluthe, 1980; French & Tupin, 1974; Johnson, 1974) has 
demonstrated that relaxation is able to reduce the 
report of pain in clinical and laboratory settings.
Recent research by Cogan, Cogan, Waltz and McCue (1987) 
examined the thresholds for pressure induced discomfort 
following exposure to four different audio tapes. In 
comparing laughter-inducing, relaxation-inducing, 
dull-narrative, and no-tape conditions, discomfort
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thresholds were found to be higher for subjects in the 
relaxation and laughter conditions. A second experiment 
included the additional conditions of an interesting 
narrative and a multiplicatio task to discover whether 
laughter, and not simply distraction, reduces discomfort 
sensitivity. Discomfort thresholds only increased for 
subjects in the laughter-inducing condition.
Research (Isen, 1985; Isen, Daubman, & Nowicki, 1987; 
Isen & Gorgoglione, 1983) exists which attests to the 
impact of positive affective states on cognitive 
performance. Laughter has been found to be superior to 
relaxation and other audio distractions (Cogan et al., 
1987) on pressure-induced discomfort thresholds, 
although there has not been any research on the impact 
of these techniques on perceived pain tolerance.
While research indicates that female athletes are 
more tolerant of pain than non-athletic females (Davies 
& Hall, 1987; Jarmenko, Silbert & Mann, 1981) there is 
speculation as to the reasons for this difference. As 
relaxation techniques (Jacobson, 1938) can be classified 
as learned skills which require a period of training in 
order to gain proficiency, this may explain differences 
in the ability of individuals to utilize this technique. 
Elite athletes have mastered a variety of learning
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strategies, which are prerequisites for skill 
acquisition and may have access to a more extensive 
schema system (Schmidt, 1975). The ability to achieve 
competence in relaxation may place athletic females at 
an advantage in tolerating cold-pressor pain.
Laughter, according to Cogan et al. (1987), is 
naturally occurring and effortless, and has been found 
to be potentially more beneficial than other behavioral 
techniques for reducing pain sensitivity. It is 
hypothesized that laughter is less likely to result in 
treatment differences between female athletes and 
non-athletes. If the efficacy differences between 
relaxation and laughter in tolerating pressure-induced 
discomfort thresholds (Cogan et al., 1987) can be 
generalized to the cold-pressor test and to an athletic 
population, we may have to revise our use of classic 
relaxation techniques in sport.
Research is thus needed to investigate whether 
differences exist between female athletes and 
non-athletes in their ability to utilize affective and 
relaxation techniques in reducing perceived pain 
tolerance, and which treatment is more effective.
The main purposes of this study were: (a) to 
investigate the efficacy of the two treatment conditions
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and the control on the level of perceived pain tolerance 
(affect and intensity), (b) to assess whether there were 
group differences (between athletes and non-athletes) on 
the level of perceived pain tolerance (affect and 
intensity), (c) to assess whether differences existed 
between athletes and non-athletes on any of the pain 
variables, and (d) to assess the effect of time on 
perceived pain, anxiety, confidence, expectancy, 
submersion time, and heart rate.
The sub-purposes of this study were: (a) to examine 
the relationship between heart rate and the level of 
perceived pain tolerance (affect and intensity), (b) to 
examine the effect of the 3 treatment conditions on 
heart rate, (c) to investigate possible differences in 
heart rate between athletes and non-athletes, (d) to 
assess whether pretest confidence correlated with 
perceived level of pain tolerance (affect and 
intensity), and (e) to assess whether classification as 
a monitor or blunter had any effect on the perceived 
intensity and affect of pain.
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Method
Subjects
Eighteen female varsity athletes (NCAA Division 1), 
and 18 female participants from university undergraduate 
activity classes, who satisfied basic exclusion 
criteria, were randomly selected. All the subjects were 
volunteers, with the activity class members receiving 
experimental class credit. Non-athletes were randomly 
selected from volunteers who completed a questionnaire 
which assessed their current and previous participation 
in physical exercise. Non-athletic subjects were only 
eligible if they: (a) were not currently, or had not 
previously, participated in any form of representative 
sport, (b) had not previously participated voluntarily 
in organized sport for more than 2 hours a week, and (c) 
were no currently training or participating voluntarily 
in a recognized sport, for more than 2 hours each week.
Subjects were instructed not to engage in strenuous 
physical activity the evening before testing. They were 
also asked to abstain from drugs, alcohol, coffee, tea, 
and cola during the 24 hours preceding the experiment.
As a precaution against childbirth conditioning the 
subject to a higher level of pain tolerance than would
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be normally expected, any subjects with children were 
excluded from the study. Only 2 subjects, who were 
otherwise eligible, were excluded under this criteria. 
Any subjects not achieving a relaxation effect 
(determined by an examination of the sampled heart rate, 
or Likert scale), or failed to laugh (visual 
observation) at the humor tape, were excluded from the 
study. One subject was excluded from each group for not 
satisfying the above criteria.
Instruments
Cold Water Pressor Test. Pain tolerance was 
measured on the cold pressor test (Jarmenko et al., 
1981; Worthington, 1978). Botwinick (1978) indicated 
that sensory response may be fairly homogeneous for 20 
year olds, therefore the cold water pressor test 
appeared to be appropriate to facilitate the detection 
of any treatment effects. The eight inches of iced 
water was contained in a styrofoam bucket. The water 
was stirred continuously, and maintained at l-2o C by 
the frequent addition of ice.
Visual Analogue Scale The visual analogue scale 
used to assess perceived pain, consists of two 150 mm 
straight lines lines, drawn on a piece of white paper. 
The first line represents sensation, with endpoints
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designated as "no sensation" and "the strongest 
sensation I can imagine." The second line represents 
affect, with endpoints designated as "not bad at all" 
and "the most intense bad feeling for me". The lines 
can be marked with a pencil to represent the level of 
intensity or affect experienced. The instructions 
accompanying the visual analogue lines provided 
information in the form of an analogy, which clarified 
the distinction between the affective and the intensity 
dimensions of pain.
Audio Tapes Three audio tapes were used during the 
experiment. The two treatment audio tapes were George 
Carlin's "stuff tape" (1981), and a modified version of 
progressive relaxation (Jacobson, 1938), following the 
protocol of Cormier and Cormier (1979). The relaxation 
involved 15 muscle groups, which were systematically 
relaxed twice. For the purposes of standardizing 
experimenter input, the relaxation treatment was 
presented in tape form.
Miller Behavioral Style Scale (MBSS). This scale, 
developed by Miller (1979), was administered to all the 
subjects prior to the start of the pre-recorded 
instructions. A pencil and paper test, the scale is 
designed to identify monitors or blunters. The scale
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consisted of four hypothetical stress-evoking scenes of 
an uncontrollable nature. Each scenario was followed by 
eight statements, which represented different ways of 
coping with the situation. The subject simply marked 
all the statements following each scene that were 
personally applicable. Blunters are individuals who 
distract themselves from threat-relevant information. 
Conversely, monitors are individuals who seek 
threat-relevant information.
Expectancy Measures and State Anxiety Measure 
(STAI). This study included a measure of subject 
expectancy of the efficacy of the treatment to increase 
tolerance to the cold water pressor test, utilizing the 
protocol of Stefanek and Hodes (1986). Prior to the 
post-treatment cold pressor test, an expectancy 
questionnaire was administered to all subjects. The 
questionnaire consisted of five items rated on a 10 
point scale. The Borkovec and Nau (1972) expectancy 
assessment instrument was modified to emphasize the 
reported effectiveness of the treatments in increasing 
pain tolerance.
A modified version of the State Anxiety Form 
(Spielberger, Gorsuch, & Lushene, 1970) was also used. 
This self-report measure of anxiety was administered to
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the subjects before each exposure to the cold water 
pressor test. Five statements are presented on paper, 
each with a 7 point scale. The scale ranges from 1 (not 
at all) to 7 (very much so), a number being marked by 
the subject to represent their present feelings.
Heart Rate. In order to ascertain whether the 
relaxation group had achieved a more relaxed state as a 
result of the tape, heart rate was monitored 
continuously throughout the entire experiment 
(approxiamately 42 minutes). The monitor used was the 
Industrial and Biomedical Sensors Corporation automated 
blood pressure and pulse rate monitor (model SD-700A) 
which measured heart rate in beats per minute. Heart 
rate was recorded from the digital display using a 
Panasonic VHS movie camera (AG-1606), with built in 
timer. Kohn (1977) suggests that in young subjects, 
bodily systems are quicker to return to functioning 
following the introduction of a stimulus, so that heart 
rate returns to baseline more quickly. As stated 
previously, Botwinick (1978) also indicates that sensory 
functioning may be fairly homogeneous for 20 year olds. 
As the mean age of the subjects was around 20 years of 
age, heart rate appeared to be a suitable measure to 
detect stimulus response.
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Relaxation Assessment. To assess whether a state of 
relaxation had been achieved through the treatments, 
subjects were administereda visual analogue scale 
pretreatment and posttreatment. The scale consisted of 
a 15 mm line, with endpoints designated as "zero 
relaxation" and "total relaxation". Subjects were 
required to mark the line according to how they 
currently felt.
Confidence Level. Each subject's confidence in 
their ability to keep their hand submersed in ice-water 
for at least 5 minutes was assessed. A brief Likert 
type scale and a visual analogue line were presented 
before each cold water pressor test. The Likert type 
scale consisted of 4 levels of confidence ("not at all", 
"somewhat confident", moderately confident", and "very 
confident"). The analogue line consisted of a 15 mm 
line on white paper, with end points designated as "0% 
confidence" and "100% confidence."
Procedures
Each subject was provided with a brief description 
of the study and then asked to sign a consent form and 
waiver of liability before being allowed to participate. 
The testing was carried out on an individual basis. In 
the presence of one male experimenter, the subjects were
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instructed to listen carefully to the taped 
instructions, following the directions exactly.
All the subjects had their left index finger 
connected to the photoelectric sensor, so that heart 
rate could be monitored throughout the experiement.
Once a baseline rate had been assessed (approximately 12 
minutes), heart rate was recorded from the digital 
display using the camera for the duration of the 
experiment (an additional 30 minutes approximately). 
Following completion of the experiment, heart rate 
levels were sampled at 20 second intervals, using the 
built in clock. The highest and lowest heart rate 
figures were recorded each 20 seconds and then averaged 
separately over each phase of the experiment. This 
provided low and high heart rate figures for baseline 
(BASEL and BASEH), cold pressor test one (CPL1 and 
CPH1), treatment (TXL and TXH), cold pressor test two 
(CPL2 and CPH2), and pretreatment-posttreatment (C and 
CH) .
Following the protocol of Price, McGrath, Raffi, 
and Buckingham (1983, pp. 47-48), subjects were made 
familiar with visual analogue lines, and the difference 
between the intensity dimensions and affective 
dimensions of pain. They were asked to complete these
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lines to reflect their rating of the pain sensation 
intensity, and the affective magnitude of the 
experimental pain. The lines were presented at 1 minute 
intervals during the cold water pressor test, subjects 
marking the lines with a pencil held in their left hand. 
Subjects were reminded not to disturb their submersed 
hand. In order to minimize the movement of the left 
hand, the pencil was placed in the subject's hand and 
the visual analogue lines were placed under the hand.
The taped instructions then asked all subjects to 
complete a confidence Likert scale, and a short-form (5 
items) of the State Anxiety Form (Spielberger et al., 
1970). The subjects were then asked to remove jewelry 
and any restrictive clothing from their right arm. 
Subjects were seated in an upright chair, to the right 
of which was a styrofoam bucket containing eight inches 
of iced water. Comfortably seated, the subjects were 
directed to place their right arm into the bucket of 
ice water until the middle finger touched the bottom. 
Keeping the hand straight, this position was to be 
maintained until the subject could no longer tolerate 
the pain, or until 5 minutes had elapsed. This ceiling 
on submersion time was designed to minimize any danger 
to the subject, although the subjects were not told
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beforehand that a time limit had been imposed.
Submersion time was measured with a hand stop-watch from 
the moment the hand entered the water until the hand was 
withdrawn.
Following withdrawal of the hand, each subject was 
randomly assigned to one of the treatment groups or the 
control group for a period of 20 minutes. To minimize 
the delay between treatment and post-test tolerance 
measurement, the treatment and control sessions were 
conducted adjacent to the test area. The subject was 
asked to listen to either the relaxation tape (seated 
on a reclining couch) or the laughter tape (seated in an 
upright chair). The control group was asked to sit 
quietly in an upright chair for 20 minutes. Before 
completing the treatment phase, subjects were asked to 
complete the expectancy questionnaire (Borkovec &
Nau,1972).
After completion of the treatment phase, the 
subjects were prompted to prepare for the second cold 
pressor test, with the instructions again asking them to 
fill in the expectancy questionnaire, STAI form, and 
confidence scale. The subjects were asked to complete 
the hand immersion under the same conditions as before, 
completing the visual analogue scales at 1 minute
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intervals.
As part of the relaxation assessment, baseline 
heart rate figures were compared with heart rate 
recordings during the relaxation treatment. The 
comparisons paired the lowest averaged (every 20 
seconds) baseline figure with the lowest averaged (every 
20 seconds) relaxation figure. The criteria for 
achieving relaxation was a reduction in heart rate of 5 
beats per minute.
Design and Analysis
The analysis involved a 3 (treatment) x 2 (groups) x 
2 (trials) MANOVA, with repeated measures on the last 
factor. The dependent variables were the visual 
analogue scale scores (measured in mm) for intensity of 
perceived pain (VASI) and affect of perceived pain 
(VASA), time of submersion, heart rate measures, 
expectancy rating, anxiety scores, and confidence level. 
A multivariate mixed model (MMM) repeated measures 
analysis (Schultz & Gessaroli, 1987) was selected for 
the study. The MMM analysis is an extension of the more 
common univariate mixed model ANOVA, the presence of 
multiple dependent measures necessitates a multivariate 
approach. The multivariate test statistics are applied
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to the multiple dependent measures but not to the 
repeated measures, providing more power than if a 
multivariate treatment was used on the repeated measure 
and yet still providing for experimentwise control over 
Type 1 error rate (inflated when separate analyses are 
used for each dependent variable).
If the multivariate F was significant (using the 
Hotelling-Lawley Trace to provide an approximate F 
statistic), the relative contribution of each dependent 
variable was examined with univariate ANOVAs.
Conducting multiple ANOVAs following a significant 
MANOVA may produce inflated Type 1 error rates, although 
the significant multivariate F does provide an overall 
protection. All post-hoc analyses were performed using 
ANOVA procedures and a .05 level of significance was set 
a priori for all effects.
Follow-up multiple comparisons were conducted using 
the Student Newman Keuls (SNK) procedure (Harris, 1975) 
to evaluate group differences and treatment differences 
between the pretest and posttest scores on the pain 
variables. The SNK procedure was also used to evaluate 
whether significant differences existed between the 
groups on pretest score and treatment groups on pretest 
scores.
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Separate MANOVA analyses were conducted on both the 
single measure pain variables (MONT, BLUNT, and EXPECT), 
and the heart rate data. The dependent measures for 
heart rate were: low heart rate for pretreatment and 
posttreatment cold water pressor test (C), high heart 
rate for pretreatment and posttreatment cold water 
pressor test (CH), low heart rate during baseline 
(BASEL), high heart rate during baseline (BASEH), low 
heart rate during treatment (TXL), and high heart rate 
during treatment (TXH). Lowest and highest heart rate 
figures were selected every 20 seconds and then averaged 
over each phase of the experiment. Univariate ANOVAS 
examined the relative contribution of each dependent 
variable, and the SNK procedure evaluated whether 
significant differences existed between the groups or 
treatments pretest. SNK pairwise comparisons were also 
conducted between the combined treatment groups 
(relaxation and humor) and the control group on posttest 
perceived pain (I and A).
Correlational analyses were conducted to examine 
the relationship between the dependent variables. These 
analyses were performed by athletic group, treatment 
group, and for the entire sample.
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Results
Analyses of Variance
The repeated measures multivariate analysis on the 
pain variables revealed a significant group effect, F(7, 
24) = 2.78, p < .02, and a significant trials effect, 
F(7, 24) = 6.72, p < .01. The treatment by time 
interaction, F(14, 46) = 2.65, £ < .01,and the group by 
treatment interaction, F(14, 46) =7.59, £ < .01, were 
both significant. No other effects or interactions in 
this analysis were significant.
Analyses on Intensity (I) and Affect of Pain (A)
Univariate ANOVAs revealed a significant group 
effect on the pretest posttest visual analogue for pain 
intensity (I), F (1,30) = 6.89, £ < .05, and a 
significant treatment condition effect, F(2, 30) = 3.29, 
£ < .05 follow-up Student Newman-Keuls revealed 
significant group differences, with the non-athletic 
group recording significantly higher levels on I. The 
SNK on treatment condition effect revealed no 
significant pairwise differences between groups. 
Subsequent contrasts between the control group and the 
two treatment groups combined produced significance,
F(2, 30) = 3.75, £ < .05, with the control group 
recording significantly higher levels (M = 502.89, sd =
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184.99 and M = 362.30, sd = 171.74, respectively).
Univariate ANOVAs on the pretest posttest visual 
analogue for pain affect (A), revealed a significant 
group effect, F(l, 30) = 10.79, p < .01, a significant 
treatment condition effect, F(2, 30) =3.19, p < .05, 
and a significant time effect, F(l, 30) =6.84, p < .01. 
Follow-up SNK revealed significant group differences, 
with the non-athletic group recording significantly 
higher levels on A. The SNK on treatment condition 
effect failed to detect significant pairwise differences 
between groups. Subsequent contrasts between the 
control group and the two treatment groups combined 
produced significance, F (2, 30) = 3.78, p < .05, with 
the control group recording significantly higher levels 
(M = 485.61, sd = 189.59 and M = 306.19, sd =
170.85,respectively). The SNK performed for the time 
factor indicated that higher posttest times were 
recorded across groups and across treatments.
The SNK performed on I and A to assess pretest 
differences found that there were no significant 
differences (p > .05) between the three treatment 
groups. Significant group differences (p < .05) were 
found between the pretest non-athletes andathletes, with 
the non-athletes recording the higher scores.
Effects of Laughter and Relaxation on Pain Tolerance
Insert Figure 1 and Tables 1 & 2 about here 
Insert Figure 2 and Tables 3 & 4 about here
Univariate ANOVAs revealed a significant time 
effect on the pretest posttest state anxiety level 
(STAI), F(1,30) = 39.89, p < .0001. Follow-up SNK 
revealed that lower levels of anxiety were achieved on 
the posttest, across athleticism groups and treatment 
groups (M = 15.75, sd = 4.66 and M = 11.14, sd = 5.14,
respectively). The SNK conducted to assess pretest 
differences between treatment conditions found no 
differences. The SNK on pretest group anxiety levels 
found no significant differences. Significant 
differences (p <.05) were found between the non-athletes 
at pretest and the non-athletes and athletes at 
posttest.
Analyses on Submersion Time (TM)
Univariate ANOVAs revealed a significant group 
effect on the pretest posttest time of submersion factor 
(TM), F(l,30) = 4.99, p < .03. Follow-up SNK revealed 
significant group differences, with the athletes 
recording significantly higher times than the
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non-athletes (M = 290.61, sd = 39.98 and M = 233.69, sd 
= 109.27, respectively). The SNK conducted to assess 
pretest differences found that athletes were 
significantly higher on time than non-athletes at 
pretest and posttest. Athletes achieved significantly 
higher times (£ < .05) from pretest to posttest, 
differences for non-athletes pretest to posttest were 
not significant.
Analyses on Confindence (CV and CS)
Univariate ANOVAs revealed a significant group 
effect, F(l,30) = 20.22, £ < .0001, and a significant 
time effect, F(l, 30) = 5.33, £ < .02 on the pretest 
posttest confidence scale (CS). Follow-up SNK revealed 
significant group differences, with the athletes group 
recording significantly higher levels than the 
non-athletes (M = 3.53, s d =  .74 and M = 2.41, sd =
1.05, respectively). The SNK for time indicated that 
scores for the posttest confidence scale were 
significantly higher across athleticism groups and 
treatment groups (M = 2.78, sd = 1.04 and M = 3.16, sd =
1.05, respectively). The SNK conducted to assess 
pretest differences between treatment conditions found 
no differences. Significant differences (£ < .05) were
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found beween the athletes and non-athletes at pretest 
and posttest, the athletes achieving the higher score. 
Significant differences(p < .05) were also found between 
the non-athletes pretest and posttest scores, posttest 
scores being higher.
Univariate ANOVAs revealed a significant group 
effect, F(1, 30) = 19.50, p < .0001, and a significant 
time effect, F(l, 30) = 8.11, p < .007 on the pretest 
posttest confidence visual analogue scale (CV). The 
follow-up SNK revealed significant group differences, 
with the athletic group recording significantly higher 
levels than the non-athletes (M = 121.23, sd =27.22 and 
M = 74.86, sd = 48.84, respectively). The SNK for time 
indicated that scores for the posttest confidence scale 
were significantly higher across athleticism groups and 
treatment groups (M = 87.75, sd = 42.95 and M = 108.39, 
sd = 46.59, respectively). The SNK on pretest group 
levels found significant differences (p < .05) between 
athletes and non-athletes, athletes being more 
confident. Significant differences (p < .05) were also 
found between pretest and posttest non-athletes, the 
posttest group achieving the higher scores.
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Analyses on Relaxation (RE)
Univaraite ANOVAs revealed a significant time 
effect, F (1, 30) = 25.41, £ < .0001, on the pretest 
posttest relaxation scale (RE). The follow-up SNK 
revealed significant time differences, with the posttest 
group recording significantly higher levels than the 
pretest (M = 105.78, sd = 28.77 and M = 80.92, sd = 
24.41, respectively). The SNKs conducted to assess 
pretest differences for treatment conditions found no 
significance. Significant differences (p < .05) were 
found between the posttest relaxation group and the 
posttest humor and control groups (M = 120. 75, sd = 
21.74, M = 97.17, sd = 32.59, and M = 99.41, sd = 26.91 
respectively), the relaxation group achieving higher 
scores. Significant differences (p < .05) were found 
between athletes and non-athletes (M = 89.5, sd = 24.05, 
and M = 72.30, sd = 22.19 respectively). Posttest 
relaxation scores for non-athletes were significantly 
higher (p < .05) than pretest relaxation scores for 
non-athletes.
Analyses on Single Measure Pain Variables
The MANOVA on the single measure pain variables 
(MONT, BLUNT, EXPECT) revealed a significant group
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effect, F(3,28) = 2.93, £ < .05. Independent ANOVAs 
revealed a significant group effect, F(l, 30) = 4.71, £
< .03, for monitors (MONT). Follow-up SNK revealed 
significant group differences with the non-athlete 
recording higher monitor scores than athletes (M = 
10.94, sd = 2.39 and M = 9.16, sd = 2.45, 
respectively). Independent ANOVAs for blunters (BLUNT) 
and expectancy (EXPECT) failed to produce any 
significant differences.
Analyses on Heart Rate
The repeated measures MANOVA on heart rate revealed 
a significant effect for time, F(5, 26) = 3.23, £ <.02. 
No treatment, group, or treatment by group interaction 
effects on heart rate were found to be significant. 
Independent ANOVAs on the lowest heart rate readings 
during pretreatment and posttreatment cold water pressor 
tests (C) revealed a significant time effect, F(l, 30) =
11.81, £ < .001. Follow-up SNK indicated a significant 
decrease in heart rate across groups and across 
treatments for the variable C (M = 71.44, sd = 12.21 and 
M = 68.28, sd = 12.27, respectively).
Univariate ANOVAs on the highest heart rate 
readings during pretreatment and posttreatment cold
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water pressor tests (CH) revealed a significant time 
effect F(l,30) = 17.24, p < .00031. Follow-up SNK
indicated a significant decrease in heart rate across
groups and across treatments for the variable CH (M =
78.39, sd = 12.66 and M = 75.30, sd = 13.14,
respectively). The group effect for CH narrowly failed 
to achieve significance at the £ <.05 level, F(l, 30) = 
3.58, £ < .06.
The analysis revealed no significant differences 
pre-test or posttest between baseline and treatment 
heart rates for group, treatment, or the group by 
treatment interaction.
Correlational Analyses
Pearson r analyses within the entire group, and by group 
and treatment, produced correlations which in general 
provided validity checks for the variables selected. 
Pearson r analyses indicated ratings of pretest 
relaxation (RELAX1) to be significantly negatively 
correlated with anxiety (STAI1), r = -.65, p < *0001. 
This correlation was strengthened for the posttest, r = 
-.73, p < *0001. The two measures of confidence (CONFS 
and CONFV) were highly correlated, r scores (VASI and 
VASA), r = -.38, p < .02, and posttest, r = -.54 p < 
.0006. Scores for monitors, blunters and expestancy
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failed to achieve significant correlations with most of 
the other varaibles. Time was highly correlated with 
most of the pain variables, mainly as a result of the 
low variability in submersion times.
Confidence self-report scores (CONFS) were 
negatively correlated with perceived intensity of pain 
(VASI) at pretest, r = .54, £ < .0008, and at posttest, 
r = .65, p < .0001. Confidence visual analogue scores 
(CONFV) were negatively correlated with VASI at pretest, 
r = .49, £ < .002, and posttest, r = .66, £ < .001. 
Similar correlations were recorded between perceived 
affect of pain (VASA) and both confidence scales.
General Discussion
The major objective of this study was to assess the 
effect of the different treatments on perceived pain 
tolerance (intensity and affect). The significant 
treatment effect obtained, when followed up with 
pairwise contrasts, indicated that the humor and 
relaxation treatments combined, significantly reduced 
perceived pain (intensity and affect) over the control 
group. While failing to support Cogan et al. (1987), 
these results indicate that humor has potential as a
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legitimate technique in reducing an individual's 
perception of pain. Greater sophistication in 
administering humor treatments may illustrate further 
pain attenuation applications.
A second objective of this study was to assess 
differences between athletes and non-athletes on their 
levels of perceived pain tolerance (intensity and 
affect). The significant differences found between 
athletes and non-athletes on both the pretest and 
posttest VASI and VASA scales further supports results 
reported by Davies and Hall (1987) and Jarmenko et al 
(1981). These results support the idea of female 
athletes being able to break away from the stereotypical 
socialization process which conditions females into have 
a low tolerance for pain. An alternative hypothesis 
could involve increased exposure to pain stimuli. 
Participation in athletics may increase an individual's 
familiarity with aversive stimuli. Past experience may 
increase confidence to tolerate painful situations.
The analogue scale for pain affect revealed a time 
effect, affective perceptin of pain being lower at 
posttest across groups and treatment conditions.
Exposure to aversive stimuli appears to reduce the 
affective discomfort, both with the athletes and
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non-athletes were exposed to an attenuated versin of the 
athletic environment, which deconditions the individual, 
thus reducing the unpleasentness fo the sensation.
The decrease in anxiety from pretest to posttest, 
as measured by STAI, reflects increased famliarity with 
the aversive stimuli. This would appear to reduce 
uncertainty and apprehension, enabling the subjest to 
bew less anxious. As expected, athletes revealed 
significantly lower levels of anxiety at the pretest. 
This finding supports Rosillo and Fogel (1973) who 
contend that athletes are socialized into tolerating 
higher levels of pain. This socialization process would 
appear to prepare athletes for potenially painful 
experiences, thus reducing their level of anxiety. Lower 
anxiety ecperienced by the athletes may reflect their 
greater familiarity with both physical and psychological 
stressors. We can perhaps equate the idea of being 
socialized into dealing with higher levels of pain, with 
the idea of increasing exposure to a variety of aversive 
and painful stimuli over time. There is the possiblity 
that a Hawthorne effect may be operating to motivate the 
subjects to perform better on the posttest measures.
The experimental situation is open to all kinds of 
demand characteristics, and may be partially responsible
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for some the treatment differences.
Reflective of the significant differences between 
athletes and non-athletes on the visual analogues of 
pain, the time factor also produces significant 
differences. This again was expected, although 
interestingly only the athletes improved significantly 
from pretest to posttest. Thus despite non-athletes 
perceiving the pain to be less aversive at the posttest, 
this did not affect their submersion times 
significantly. Athletes would appear to be more 
efficient in utilizing the increased proprioceptive and 
nociceptive (pain receptors) information, resulting not 
only in reduced perceived pain but increased submersion 
times.
Relaxation levels were higher in the athletes than 
the non-athletes. As with confidence levels, increases 
were achieved pretest to posttest which reflect the 
increased familiarity with the task requirements. Thus, 
the lowered affective dimension of the pain visual 
analogue may be partly due to the subjects feeling more 
at ease. The posttest relaxation scores (RE) were 
significantly higher than the humor or control group, 
validating the reaxation treatment technique. The 
relaxation treatment subjects self-reported deeper
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relaxation than the other treatment groups.
The measures for expectancy and blunting did not 
produce any differences between the groups or the 
treatments. This may reflect a lack of sensitivity in 
the questionaires designed to assess these particular 
dimensions. Monitors were higher in non-athletes which 
may be reflective of their increased uncertainty in 
unfamiliar situations. The results suggest that these 
dimensions, as measured by the current instruments, do no 
elucidate variations in individual pain tolerance. As 
Miller (1979) suggested, monitors prefer predictability 
under threat, placing the non-athletes at a disadvantage 
in this pain study. Possibly, non-athletes higher in the 
monitoring dimension may have a less adaptive or 
extensive repertoire of cognitive coping skills. This 
would appear to be an important consideration in the area 
of pain tolerance, and needs to be assessed with greater 
sophistication.
The correlation analyses provide support where 
expected, and serve as useful validity checks in the 
case of the anxiety and relaxation measures. Confidence 
scores for both self-report and visual analogue were 
negatively correlated with both dimensions of perceived 
pain (VASI and VASA), but only for the entire group.
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When broken down into correlations by group and 
treatment, the trend was maintained although 
significance was low. More precise instruments may 
result in more informative and discriminatory 
correlations.
The heart rate results support Grimm and Kanfer 
(1976) in indicating that a reduced level of 
physiological arousal, as measured by heart rate, is not 
always accompanied by increases in perceived pain 
tolerance. No differences were found between or within 
treatments or groups. The significant decrease in heart 
rate levels for the entire group between the pretest and 
posttest cold water pressor tests validate the posttest 
changes in measures of relaxation, anxiety, and 
confidence. Greater sophistication in assessment may be 
needed to identify more precisely the relationship 
between pain and physiological response. Such measures 
may well have to be more intrusive than measuring heart 
rate.
The different results achieved between VASI and 
VASA support Price et al. (1983) in validating the 
ability of visual analogue scales to discriminate 
between the intensity and affective dimensions of pain.
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While inconclusive, these results indicate that 
humor can be utilized in modifying an individual's 
perception of pain (intensity and affect). Additional 
work is needed in the area of humor before we can become 
unequivocal in proclaiming the therapeutic benefits. 
Humor is by definition a subjective interpretation, 
which makes the task of assessment and quantification 
problematic. Further research examining the role of 
endorphins in pain tolerance is needed to increase our 
understanding of the psychobiological mechanisms behind 
humor. Any invasive assessment measure would make the 
development of a "humorous atmosphere" difficult, but 
would increase the explanatory sophistication if 
feasible.
Despite the lack of unequivocal empirical support, 
humor appears to have potential utility in a number of 
applied settings. While extrapolation from laboratory 
settings to applied areas has a tendency to be 
problematic, in addition to perceived pain modification, 
humor may also be beneficial in areas such as 
pre-competitive anxiety management and in reducing 
training burnout.
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Figure captions
Figure 1. Visual analogue intensity means plotted 
pretreatment and posttreatment.
Figure 2. Visual analogue affect means plotted 
pretreatment and posttreatment.
Figure 3. Treatment condition differences for pretest
posttest heart rate during cold water pressor 
tests.
Figure 4. Treatment condition differences for athletes 
and non-athletes on pretest and posttest 
heart rate during cold water pressor tests.
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The Effects of Relaxation and Laughter on the 
Perceived Intensity and Affect of Pain Tolerance
Pain is currently conceptualized as a complex 
phenomenon resulting from the interaction of cognitive, 
motivational and sensory components (Tan, 1982). In 
examining pain, laboratory studies frequently employ 
experimentally induced pain, whether from cold pressor 
(tolerance to ice water) or muscle ischemia. Pain 
threshold, pain tolerance, and subjective pain ratings 
are frequently utilized as the main dependent measures. 
Pain threshold refers to the point at which the 
stimulation is just perceived as painful by the 
individual. Pain tolerance refers to the point at which 
an individual is not prepared to accept stimulation of a 
higher or equal magnitude (Weisenberg, 1977).
Contradictory and inconclusive data exist with 
regard to the impact of sex differences on pain 
experience, but consensus indicates that pain threshold 
does not vary between males and females, whereas pain 
tolerance is greater in males (Otto & Dougher, 1985; 
Wescott, Huesz, Boswell, & Herold, 1977).
Research by Petrie (1960) indicated the existence 
of a relationship between perceptual variables and 
individual pain experience, which resulted in two
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perceptual styles. Augmenters were found to enlarge 
upon the intensity of the incoming stimulus, thus 
increasing the subjective evaluation of what is 
perceived, resulting in the experience of more pain and 
the greater tolerance of sensory isolation. At the 
other end of the continuum, reducers were found to 
reduce the intensity of the incoming stimulus, resulting 
in the experience of less pain and less tolerance of 
sensory isolation. Women were found to reduce less than 
men, resulting in a lower pain tolerance. Petrie 
suggests that female pain perception is inextricably 
interwoven with the concept of survival, explaining the 
tendency of females not to reduce sensations which have 
survival value. It would appear that both cultural and 
perceptual style differences are partially responsible 
for sex differences in pain tolerance.
Miller (1979) developed the "blunting hypothesis" 
which stated that once an individual becomes 
psychologically aware of a confronting physical danger 
signal, cognitive strategies can be adopted which remove 
the individual from any further psychological awareness, 
lowering the arousal level. Individuals adopting the 
strategies which shield or remove them from danger 
signals are termed "blunters". Blunters tend to reduce 
the psychological impact of physically present danger 
signals. Positive strategies utilized would include
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reinterpretation, distraction, and self-relaxation.
Less positive strategies would involve detachment, 
intellectualization, and denial (Vaillant, 1977). 
Conversely, "monitors" seek out threat-relevant 
information. Such individuals are able to discriminate 
changes in the external environment. Research by Monat, 
Averill and Lazarus (1972) found that subjects found it 
easier to distract under unpredictable conditions and 
under low intensity threat. Miller (1979) specified the 
conditions under which predicatability elicits stress 
reducing effects and when it does not. Subjects were 
classified as preferring predictabilty under threat 
("monitors") or as preferring unpredicatability 
("blunters").
Lazarus and Alfert (1965) demonstrated that such 
techniques reduced the level of psychophysiological 
arousal typically associated with vicarious stressors 
(gory films). Miller (1980) found that subjects were 
able to engage themselves in various cognitive 
strategies to blunt the psychological impact of 
physically present danger (colposcopy), and thus reduce 
arousal as measured by pulse rate. Miller (1979) also 
found that predictability was preferred and less 
arousing under invasive and intrusive conditions which 
did not support blunting strategies. Unpredictability 
was preferred and less arousing under noninvasive and
47
nonintrusive conditions which supported blunting 
strategies.
Petrovich (1958), using pictures of men undergoing 
various painful experiences, found that the estimated 
pain intensity and estimated duration of pain was 
significantly greater by females. Woodrow, Friedman, 
Siegelaub and Collen (1972) induced pain by applying 
pressure to the achilles heel. They found that men 
tolerated greater pain than women, with the findings 
holding across age. Merksy and Spear (1964) also found 
that men tolerated significantly more pain than women, 
whereas Notermans and Tophoff (1967) found no 
differences in pain threshold between the sexes.
Jarmenko, Silbert and Mann (1981) reported that 
female athletes possessed a higher tolerance for 
aversive stimuli than female non-athletes, male 
athletes, and male non-athletes. This higher level of 
tolerance was demonstrated by a large rejection rate 
amongst the female athletes due to reaching the ceiling 
level on submersion time in the cold pressor pre-test. 
Female non-athletes showed the least tolerance on the 
test.
Shumate and Worthington (1987) claim that the cold 
pressor test has provided an analogue to acute clinical 
pain for which the effectiveness of various behavioral 
and cognitive strategies has been examined (Worthington,
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1982; Worthington & Martin, 1980; Worthington, Martin & 
Shumate, 1982; Worthington, Martin, Shumate & Carpenter, 
1983). The cold pressor test has also been used to 
investigate other pain control techniques such as 
distraction through imagery (Chaves & Barber, 1974; 
Greenstein, 1984; Horan & Dellinger, 1976; Scott & 
Leonard, 1978; Worthington, 1978; Worthington &
Schumate, 1981). Davies and Hall (1987) found that 
female non-athletes perceived pain induced by a cold 
water pressor test to be significantly higher than their 
athletic counterparts in both affect and intensity. 
According to Elton, Stanley & Burrows (1983), pain has 
evolved into a very complex, multi-level, interacting 
explanatory system, involving neurological, biochemical, 
personality and psychosocial variables. Accepting that 
pain does not appear to be experienced in only one 
dimension, several researchers have suggested that the 
experience of pain sensations is not necessarily 
accompanied by affective feelings of being hurt 
(Beecher, 1959; Meichenbaum, 1977; Stevens & Heide, 
1977). Gracely, Dubner and McGrath (1979) have 
demonstrated that the intensity and unpleasantness 
dimensions of pain can be assessed separately, and can 
thus be affected differentially by treatments.
Harris and Rollman (1983) found that measures of 
tolerance and threshold revealed generality and
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discriminant validity across stressors. They stressed 
that threshold judgments, which emphasized 
discrimination of nociceptive quality, and tolerance 
decisions which indicated an unwillingness to receive 
more intensive stimuli, are not equivalent measures of 
responsivesness. It would appear to be more productive 
to examine pain tolerance in isolation, as it is this 
dimension of pain which is more likely to be effected by 
sociological or psychological variables.
Research suggests the need to assess at least the 
intensity and affective dimensions of pain in attempting 
to gauge the individual response to aversive stimuli.
The visual analogue scales (VAS) have been reported as 
valid and reliable measures for both the intensity and 
unpleasantness involved in experimental pain (Levine, 
Gorden, & Fields, 1982; Scott & Huskisson, 1976).
The VAS scale is considered by Scott and Huskisson 
(1976) to be one of the best methods available for the 
estimation of pain intensity. The VAS provides a 
continuous scale for magnitude estimation and consists 
of a straight line, the ends of which represent the 
extremes of pain experience. Carlsson (1983) suggests 
that the VAS format is preferable to discontinuous 
methods such as numerical and verbal rating scales.
High correlations have been reported between VAS and 
numerical rating scales (Elton, Burrows, & Stanley,
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1979; Ohnhaus & Adlev, 1975; Scott & Huskisson, 1976; 
Woodforde & Merskey, 1972).
In contrast to Jarmenko et al. (1981), the female 
athletes in the study conducted by Davies and Hall 
(1987) did not differ significantly from the male 
athletes on either the perceived intensity, or affect, 
of pain. These conflicting results may be explained by 
the presence of one male and one female experimenter, 
unlike the Jarmenko et al. study which used two male 
experimenters. The athletes in the study by Davies and 
Hall were both from NCAA Division 1 track teams, as 
compared to Jarmenko et al. (1981) who used NCAA 
Division IA males and Division II females. The findings 
of Davies & Hall (1987) and Iso-Ahola & Hatfield (1986) 
generally support the contention that female athletes 
indicate lower levels of perceived intensity and affect 
of pain, as compared to their non-athletic counterparts. 
Otto & Dougher (1985) contend that males and females 
have similar abilities to modulate attention, or to 
raise or lower their criteria for reporting pain, but 
use these capabilities differently.
Controversy exists over the superiority of taped as 
opposed to live relaxation training, with live 
relaxation techniques generally being acknowledged as 
being more effective in reducing tonic levels of 
physiological and cognitive arousal (Borkovec & Sides,
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1979; Lehrer & Woolfolk, 1984). Lehrer (1982) suggests 
that the source of this superiority is unclear, although 
the presence of the therapist can offer the advantages 
of therapeutic warmth and provide increased 
opportunities to supply trainees with relevant feedback 
and suggestions on how to relax.
The assessment of relaxation therapies has been 
developed by Stefanek and Hodes (1986) who postulated 
that the effectiveness of relaxation therapies was 
related to the expectancy of success. The majority of 
research comparing the efficacy of live and taped 
relaxation training frequently failed to incorporate a 
measure of expectancy (Godsey, 1980; Quayle, 1980), 
despite Beiman (1976) finding that lower expectancies 
reduced the effectiveness of brief muscle relaxation 
training procedures. In contrast, Grimm and Kanfer
(1976) found that expectancy for decreased discomfort, 
or progressive muscle relaxation, failed to increase 
cold pressor tolerance over a control group, whereas 
subjects engaged in verbal/symbolic activities increased 
their tolerance significantly. The verbal/symbolic 
group were trained in the use of potential controlling 
rsponses consisting of pleasant thoughts and scenes.
Stefanek and Hodes (1986) examined the effect of 
self, taped, and live relaxation instructions on 
physiological and self-report measures of anxiety under
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conditions of low and high treatment expectancy. They 
found that for all three relaxation procedures, the 
number of response systems benefitting from training was 
maximized when relaxation was provided within the 
context of high expectancy for change. Using a modified 
version of the Borkovec and Nau (1972) expectancy 
assessment instrument (modified to emphasize learning 
the ability to reduce general tension and anxiety), 
Stefanek and Hodes found that palpable effects were 
produced across both physiological (heart rate, 
spontaneous skin fluctuations, finger pulse) and verbal 
(self-report) response systems. Self-report was 
measured using the Anxiety Differential (Husek & 
Alexander, 1963).
In contrast, Grimm and Kanfer (1976) found that 
significant heart rate decreases were only found in the 
verbal/symbolic activities and relaxation treatment 
groups. The expectancy for decreased discomfort group 
(induced from educational information and experimental 
reports on ice pressor tolerance decreasing from pre to 
post test as a result of physical adaptation) failed to 
achieve any post-test increase in tolerance level.
Thus, expectancy alone, without the associative 
influence of relaxation, does not appear to increase 
tolerance to ice-water pain. Grimm and Kanfer (1976) 
also stress that the failure to note increases in
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tolerance (beyond the control group) by the 
relaxation-analog group in conjunction with decreases in 
heart rate, suggests that autonomic change alone is not 
sufficient to affect pain tolerance.
Kazdin and Wilcoxon (1976) suggest that changed 
expectancy is the basis of therapeutic effects, although 
Wolpe (1982) emphasizes that they offer no evidence for 
the therapeutic efficacy of expectancy. Wolpe (1982) 
suggests that there are only two possible therapeutic 
roles for expectancy which are discernible. Expectancy 
implies a hopeful belief which may displace contrary 
cognitions and any associated fears, this aroused 
expectancy possibly competing with anxiety.
Research (Isen, 1985; Isen, Daubman, & Nowicki,
1987; Isen & Gorgoglione, 1983) exists which attests to 
the impact of positive affective states on cognitive 
performance. Laughter has been found to be superior to 
relaxation and other audio distractions (Cogan et al., 
1987) on pressure-induced discomfort thresholds, 
although there has not been any research on the impact 
of these techniques on perceived pain tolerance.
While research indicates that female athletes are 
more tolerant of pain than non-athletic females (Davies 
& Hall, 1987; Jarmenko et al. 1981) there is speculation 
as to the reasons for this difference. As relaxation 
techniques (Jacobson, 1938) can be classified as learned
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skills which require a period of training in order to 
gain proficiency, this may explain differences in the 
ability of individuals to utilize this technique. Elite 
athletes have mastered a variety of learning strategies, 
which are prerequisites for skill acquisition, and may 
have access to a more extensive schema system (Schmidt, 
1975). The ability to achieve competence in relaxation 
may place athletic females at an advantage in tolerating 
cold-pressor pain.
Laughter, according to Cogan et al. (1987), is 
naturally occurring and effortless, and has been found 
to be potentially more beneficial than other behavioral 
techniques for reducing pain sensitivity. If the 
efficacy differences between relaxation and laughter in 
tolerating pressure-induced discomfort thresholds (Cogan 
et al. , 1987) can be generalized to the cold-pressor 
test and to an athletic population, we may have to 
revise our use of classic relaxation techniques in 
sport.
Despite numerous anecdotal references to the 
therapeutic effectiveness of laughter (Hopson, 1988), 
empirical support is sparse. There have been attempts 
to link the cause of laughter's beneficial affects to 
endorphins. Temporary respite from severe pain appears 
to be connected to the relief of brain opiates which are 
activated as a survival mechanism, producing natural
pain relief. Researchers have located a pain control 
system in the periaqueductal gray (PAG), a central 
region within the brain responsible for the production 
of opioid peptides. Without understanding the 
mechanisms, it has been found that if the PAG is jolted 
with electrical current, chronic pain can be reduced.
Gintzler (1980) has postulated that the 
endorphin-mediated increases in pain tolerance occur 
during human pregnancy. In experiments with rats, pain 
threshold increases were abolished by the long-term 
administration of the narcotic antagonist naltrexone. 
Baron and Ginttzler (1987) have suggested that 
pregnancy-induced analgesia depends upon central rather 
than peripheral opioid systems.
In assessing the role of endorphins and exercise, 
Morgan (1985) suggests that there is a tenable, but as 
yet not empirical, relationship between exercise and 
improved mood. The improved mood may be the result of:
1. distraction, 2. monoamine release, or 3. endorphin 
release. Farrell (1985) reported that an increase in 
the peripheral plasma levels of beta endorphins in 
humans after exercise has been noted by all 
investigators to date. These findings apply equally 
well to females, where McArthur (1985) has reported a 2 
to 3 fold increase over basal levels. Numerous 
researchers (see review by Sutton, 1984) support the
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analgesic properties of endorphins, which appear to be 
mediated via specific receptors.
Accepting the analgesic properties of endorphins, 
which are activated in someway by physical exertion or 
exercise, we need to examine the effect on pain 
perception. Janal, Colt, Crawford-Clark, and Glausman 
(1984) examined the relationship between pain 
sensitivity, mood, and plasma levels in males following 
long-distance running. In comparing the effects induced 
by naloxone (opioid inhibitor) and saline (placebo), 
Janal et al. found that under saline conditions, 
discriminability was significantly reduced post-run, a 
hypoalgesic effect. Ischemic pain reports were 
significantly reduced post-run, also a hypoalgesic 
effect. Joy, euphoria, cooperation, and 
conscientiousness were also increased post-run.
Nalaxone reversed the post-run ischemia but not the 
thermal hypoalgesic effects. The naloxone effects 
suggests that the endogenous opioid neural systems are 
not mechanisms for all the run-induced alterations in 
mood and pain perception. These results are consistent 
with the findings of Haier (1981) and Colt, Wardslaw, 
and Frantz (1981). Perhaps the best way to assess the 
laughter-endorphin link would be to tap the 
cerebrospinal fluid, which Fry (1988) suggests is 
difficult and not conducive to laughter.
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Conclusions
This review of literature indicates that further 
research is still needed to assess the efficacy of humor 
as a modulator of pain tolerance. Three main questions 
were postulated in this study. First, what role does 
laughter play in modulating pain tolerance, from both an 
affect and intensity perspective? Second, does gender 
have an influence in pain tolerance? Thirdly, what role 
do endorphins have in pain tolerance?
Whilst empirical evidence for the therapeutic 
benefit of laughter is limited, anecdotal support is 
both impressive and diverse. Currently, the mechanisms 
responsible are not clearly understood.
In examining the effect of gender on pain 
tolerance, Davies & Hall (1987) report that female 
athletes achieve lower levels of perceived intensity and 
affect of pain, in comparison with female non-athletes. 
Athletic participation, at least at the more elite 
level, appears to be instrumental in overcoming the 
traditional socialization process. Female athletes are 
more similar to males in their ability to tolerate pain.
Various researchers suggest that endorphins are 
instrumental in modifying pain tolerance (whether in an 
exercise or clinical setting), although assessment is 
complicated by measurement limitations and great 
individual variation in response to treatments.
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Intrusive assessment has the potential for being highly 
accurate, but is generally incompatible with engendering 
a state of laughter!
With the addition of more empirical evidence the 
parameters and relationships between laughter and pain 
tolerance will be more clearly understood, facilitating 
greater practical application.
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Appendix B
The Biographical Questionnaire 
BIOGRAPHICAL DATA SHEET
Please answer the following questions. There are no 
right or wrong answers. Your information will be kept 
in strictest confidence. Some questions may not apply 
to you, please mark these questions with "N/A".
1. Name (please print in block capitals):
2. Date of Birth:
3. Height: 4. Weight:
5. Place of Birth (give town and state):
6. Please list any sports or recreational activities in 
which you have participated on a regular basis. Include 
the number of years of involvement, and your highest 
level of representation (i.e., recreational, high 
school, state, varsity, e.t.c.):
7. Please list any sport or recreational injuries you 
have suffered (include approximate age at the time of 
injury):
8. Please list any brothers and sisters you have, 
include ages:
9. Please list any sports played (now or previously) by 
your parents or brothers/sisters. Give the highest 
level of performance achieved by each individual in each 
sport you list (i.e., recreational, high school, state, 
varsity, e.t.c. ) :
10. What sports or recreational activities did you play 
at high school? Please list how frequently you 
participated in each activity listed (e.g. softball: 
twice a week during spring semester, from age 12 to 
16),and at what level you played at (i.e., tennis: 
school team; swimming: recreational; track: all-state). 
Please state whether your participation was voluntary or 
compulsory:
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11. Which of the following statements applies to you?
a. I have never enjoyed sports.
b. I participate in competitive sports on a regular
basis.
c. I enjoy sports but do not have the time to 
participate.
d. I engage in a limited number of sports in order to
maintain a reasonable level of fitness.
e. I enjoy sports on a recreational basis.
12. What career do you wish to pursue upon graduating?
13. Do you belong to any sports clubs, either on or off 
campus?
Please list these clubs, indicating what activities you 
participate in, and how many hours you spend on them 
each week.
14. How many hours do you spend a week playing sport or 
participating in physical recreation?
a. less than one.
b. between two and three.
c. between four and five.
d. more than five (specify number of hours).
15. Do you think that sports should be compulsory at 
high school or university (if your answer is yes, please 
suggest the number of hours and the type of sports) ?
16. List the sports (in order of preference) you would 
participate in if time and money were no object.
17. Assuming sport was compulsory at university, would 
you choose a physical contact or non-physical contact 
sport? (explain your choice).
Appendix C 
Visual Analogue Scales
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Appendix C 
Visual Analogue Scales 
INSTRUCTIONS
MARK THESE TWO LINES ACCORDING TO HOW STRONG (INTENSITY) 
OR UNPLEASANT YOU FIND THE PAIN. THE
FURTHER TO THE RIGHT YOU MARK THE LINE,THE GREATER THE 
STRENGTH/INTENSITY OR UNPLEASANTNESS.
STRENGTH OF PAIN (INTENSITY)
HOW STRONG THIS PAIN FEELS TO YOU
NO SENSATION STRONGEST
I CAN IMAGINE
AFFECT OF PAIN (UNPLEASANTNESS)
HOW UNPLEASANT THIS PAIN FEELS TO YOU.
NOT BAD AT ALL THE MOST INTENSE 
BAD FEELING FOR ME
Appendix D 
Relaxation Protocol
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Muscle Groups and Directions for Relaxation
1. Fist of right hand. "First think about your right 
arm, your right arm in particular. Clench your fist 
tight. Clench it tightly and study the tension in the 
hand and in the forearm. Study those sensations of 
tension. (Pause.). Now let go. Just relax the right hand 
and let it rest on the arm of the chair. (Pause). Note 
the difference between the tension and the relaxation".
2. Wrist of right arm. "Now bend your right hand back at 
the wrist so that you tense the muscles in the back of 
the hand and in the forearm. Point your fingers towards 
the ceiling. Study the tension, and now relax. (Pause). 
Study the difference between tension and relaxation." 
(10-second pause).
3. Right bicep. "Now clench your right hand into a fist 
and bring it towards your shoulder. As you do this, 
tighten your bicep muscles, the ones in the upper part 
of your arm. Feel the tension in these muscles (Pause). 
Now relax. Let your arm drop down to your side. See the 
difference between the tension and the relaxation." 
(10-second pause).
4. Shoulders. "Now we'll move to the shoulder area.
Shrug your shoulders. Bring them up to your ears. Feel
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and hold the tension in your shoulders. (Pause). Now, 
let both shoulders relax. Note the contrast between the 
tension and the relaxation that's now in your 
shoulders." (10-second pause).
5. Forehead. "Now we'll work on relaxing the various 
muscles of the face. First, wrinkle up your forehead 
and brow. Do this until you feel your brow furrow.
(Pause). Now relax. Smooth out the forehead. Let it 
loosen up." (10-second pause).
6. Eyes. "Now close your eyes tightly. Can you feel 
tension all around your eyes? (5-second pause). Now 
relax those muscles, noting the difference between the 
tension and the relaxation." (10-second pause).
7. Tongue or jaws. "Now clench your jaws by biting your 
teeth together. Pull the corners of your mouth back. 
Study the tension in the jaws. (5-second pause). Relax 
your jaws now. Can you tell the difference between the 
tension and relaxation in your jaw area?" (10-second 
pause).
8. Pressing the lips together. "Now press your lips 
together tightly. As you do this, notice the tension 
around all the mouth. (Pause). Now relax those muscles 
around the mouth. Enjoy this relaxation in your mouth
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area and your entire face." (Pause).
9. The head. "Now we'll move to the neck muscles. Press 
your head back against your chair. Can you feel the 
tension in the back of your neck and in your upper back? 
Hold the tension. (Pause). Now let your head rest 
comfortably. Notice the difference. Keep on relaxing."
(Pause).
10. Chin in chest. "Now continue to concentrate on the 
neck area. Bring the head forward. See if you can bury 
your chin into your chest. Note the tension in the front 
of your neck. Now relax and let go." (10-second pause).
11. The back. "Now direct your attention to your upper 
back area. Arch your back like you're sticking out your 
chest and stomach. Can you feel the tension in your 
back? Study that tension. (Pause). Now relax. Note the 
difference between the tension and the relaxation." 
(10-second pause).
12. Chest muscles. "Now take a deep breath, filling 
your lungs, and hold it. Feel the tension all through 
your chest and into your stomach area. Hold that 
tension. (Pause). Now relax and let go. Let your breath 
out naturally. Enjoy the pleasant sensations."
(10-second pause).
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13. Stomach muscles. "Now think about your stomach. 
Tighten up the muscles in your abdomen, pulling your 
stomach in. Hold this. Make the stomach like a knot.
Now relax. Loosen those muscles now." (10-second pause).
14. Legs. "I'd like you now to focus on both legs. 
Stretch both legs. Feel the tension in the thighs 
(5-second pause). Now relax. Study the difference again 
between the tension in the thighs and the relaxation you 
feel now." (10-second pause).
15. Toes. "Now concentrate on your lower legs and feet. 
Tighten both calf muscles by pointing your toes toward 
your head. Pretend a string is pulling your toes up.
Can you feel the pulling and the tension? Note that 
tension. (Pause). Now relax. Let your legs relax deeply. 
Enjoy the difference between tension and relaxation." 
(10-second pause).
Note: Each muscle group is tensed and relaxed twice.
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Miller Behavioral Style Scale
1. Vividly imagine that you are afraid of the dentist 
and have to get some dental work done. Which of the 
following would you do? Check all of the statements 
that might apply to you.
  I would ask the dentist exactly what he was going to
do.
  I would take a tranquilizer or have a drink before
going.
  I would try to think about pleasant memories.
  I would want the dentist to tell me when I would
feel pain.
  I would try to sleep.
  I would watch all the dentist's movements and
listen for the sound of his drill.
  I would watch the flow of water from my mouth to
see if it contained blood.
  I would do mental puzzles in my mind.
2. Vividly imagine that you are being held hostage by a 
group of armed terrorists in a public building. Which 
of the following would you do? Check all of the 
statements that might apply to you.
  I would sit by myself and have as many daydreams
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and fantasies as I could.
  I would stay alert and try to stop myself from
falling asleep.
  I would exchange life stories with the other
hostages.
  If there was a radio present, I would stay near it
and listen to the bulletins about what the police 
were doing.
  I would watch every movement of my captors and
keep an eye on their weapons.
  I would try to sleep as much as possible.
  I would think about how nice it's going to be when
I get home.
  I would make sure I knew where every possible exit
was.
3. Vividly imagine that, due to a large drop in sales, 
it is rumored that several people in your department at 
work will be laid off. Your supervisor has turned in 
your evaluation of your work for the past year. The 
decision about lay-offs has been made and will be 
announced in several days. Check all the statements 
that might apply to you.
  I would talk to my fellow workers to see if they
knew anything about what the supervisor's evaluation
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of me said.
  I would review the list of duties for my present
job and try to figure out if I had fulfilled them 
all.
  I would go to the movies to take my mind off of
things.
  I would push all thoughts of being laid off out of
my mind.
  I would try to think which employees in my
department the supervisor might have thought 
had done the job worst.
  I would continue doing my work as if nothing special
was happening.
4. Vividly imagine that you are on an airplane, thirty 
minutes from your destination, when the plane 
unexpectedly goes into a deep dive and then suddenly 
levels off. After a short time, the pilot announces 
that nothing is wrong, although the rest of the ride may 
be rough. You, however, are not convinced that all is 
well. Check of the statements that might apply to you. 
I would carefully read the information provided about 
safety features in the plane and make sure that I knew 
where the emergency exists were. I would make small talk 
with the passenger beside me.
  I would watch the movie end, even if I seen it
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before.
I would call for the stewardess and ask her exactly 
what the problem was.
I would order a drink or tranquilizer from the 
stewardess.
I would listen carefully to the engines for unusual 
noises and would watch the crew to see if their 
behavior was out of the ordinary.
I would talk to a passenger beside me about what was 
wrong.
I would settle down and read a book/magazine or write 
a letter.
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Expectancy Questionnaire
For each of the following statements, rate the treatment 
on each of the following 10-point credibility/expectancy 
for improvement scales:
1. How logical does this type of treatment seem to you? 
1 2 3 4 5 6 7 8 9  10
Low High
2. How confident are you that this treatment will be 
successful in increasing your tolerance to the cold 
water pressor test?
1 2 3 4 5 6 7 8 9  10
Low High
3. How confident would you be in recommending this 
treatment to a friend who wanted to increase their 
tolerance to cold water?
1 2 3 4 5 6 7 8 9  10
Low High
4. How successful do you feel this treatment would be in 
decreasing a different kind of unpleasant feeling, for 
example, dental surgery?
1 2 3 4 5 6 7 8 9  10
Low High
Appendix G
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Self-Evaluation Questionnaire 
DIRECTIONS; A NUMBER OF STATEMENTS WHICH PEOPLE HAVE 
USED TO DESCRIBE THEMSELVES ARE GIVEN BELOW. READ EACH 
STATEMENT AND THEN CIRCLE THE APPROPRIATE NUMBER (1 =
NOT AT ALL, PROGRESSING THROUGH 2, 3, 4, 5, 6, TO 7 =
VERY MUCH SO) TO INDICATE HOW YOU FEEL RIGHT NOW, THAT 
IS AT THIS MOMENT. THERE ARE NO RIGHT OR WRONG ANSWERS, 
SELECT THE NUMBER WHICH BEST REPRESENTS YOUR PRESENT 
FEELINGS. DO NOT SPEND TOO MUCH TIME ON ANY ONE 
STATEMENT.
1. I AM RELAXED
1 2
NOT AT ALL
2. I FEEL CALM
1 2
NOT AT ALL
3. I AM TENSE
1 2
NOT AT ALL
4. I FEEL AT EASE
1 2
NOT AT ALL
5. I AM JITTERY
1 2 
NOT AT ALL
6 7
VERY MUCH SO
6 7
VERY MUCH SO
6 7
VERY MUCH SO
6 7
VERY MUCH SO
6 7
VERY MUCH SO
Appendix H 
Relaxation Scale
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Relaxation Scale
HOW RELAXED DO YOU FEEL AT THIS MOMENT? MARK THE LINE 
ACCORDING TO HOW YOU FEEL. THE RANGE OF RELAXATION IS 
FROM ZERO RELAXATION TO TOTAL RELAXATION.
zero
relaxation
total
relaxation
Appendix I 
Confidence Level
90
91
Confidence Level
HOW CONFIDENT ARE YOU THAT YOU WILL BE ABLE TO KEEP YOUR 
HAND SUBMERSED IN THE ICE WATER FOR? MARK THE LINE 
WHICH BEST REPRESENTS YOUR PRESENT LEVEL OF CONFIDENCE.
Not at all Somewhat Moderately Very
Confident Confident Confident Confident
PLEASE MARK THE FOLLOWING LINE WHICH REPRESENTS A 
CONFIDENCE FOR ICE-WATER TOLERANCE CONTINUUM. THE RANGE 
IS FROM 0% CONFIDENCE TO 100% CONFIDENCE. MARK ANYWHERE 
ALONG THE LINE, INDICATING HOW CONFIDENT YOU FEEL THAT 
YOU WILL BE ABLE TO KEEP YOUR HAND SUBMERSED IN THE 
ICE-WATER FOR AT LEAST FIVE MINUTES.
0%
Confidence
> 100% 
Confidence
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Subject Consent Form
*T0 BE RETAINED BY THE EXPERIMENTER Date: ___________
Subject #: ___________
EXPERIMENT SIGN-UP FORM
My signature, on this sheet, by which I volunteer to 
participate in the experiment on tolerance of cold 
pressor stimulation, conducted by 
Mr. Simon Davies
(Experimenter), 
indicates that I understand that all the subjects in the 
project are volunteers, that I can withdraw at any time 
from the experiment, that I have been or will be 
informed as to the nature of the experiment, that the 
data I provide will be anonymous and my identity will 
not be revealed without my permission, and that my 
performance in this experiment may be used for 
additional projects. Finally, I shall be given the 
opportunity to ask questions prior to the start of the 
experiment and after my participation is complete.
Subject's Signature
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Table 1
Descriptive Statistics for Treatment Groups on VII
Treatment Groups M SD Range
Control: Athletes 463.17 216.77 193-715
Non-Athletes 584.00 183.51 293-750
Humor: Athletes 385.50 139.97 296-535
Non-athletes 429.33 207.84 161-69
Relaxation: Athletes 263.83 95.47 85-453
Non-Athletes 548.67 147.57 413-750
Table 2
Descriptive Statistics for Treatment Groups on VI2
Treatment Group M SD Range
Control: Athletes 502.33 177.43 254-715
Non-Athletes 562.00 207.54 250-750
Humor: Athletes 349.83 100.88 222-535
Non-athletes 442.33 127.48 251-694
Relaxation: Athletes 211.17 123.63 57-453
Non-Athletes 450.67 229.69 257-750
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Table 3
Descriptive Statistics for Treatment Groups on VA1
Treatment Groups M SD Range
Control: Athletes 395.33 268.42 97-733
Non-Athletes 584.00 180.65 311-750
Humor: Athletes 323.83 104.95 186-509
Non-athletes 424.67 165.58 197-624
Relaxation: Athletes 226.17 104.18 60-336
Non-Athletes 544.67 164.54 318-750
Table 4
Descriptive Statistics for Treatment; Group on VA2
Treatment Groups M SD Range
Control: Athletes 427.33 193.10 194-733
Non-Athletes 552.67 226.06 224-750
Humor: Athletes 248.50 109.86 146-509
Non-athletes 398.33 101.09 234-624
Relaxation: Athletes 180.00 78.57 77-336
Non-Athletes 397.83 237.21 213-750
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Table 5
MANOVA for Repeated Measures Pain Variables.
Source df PR > F
Group 7, 24 2.78
Treat 14, 46 1.30
Group*Treat 14, 46 7.59
Time 7, 24 6.72
Group*Time 7, 24 1.29
Treat*Time 14, 46 2.65
Group*Treat*Time 14, 46 0.96
0.0290
0.2419
0.0001
0.0002
0.2950
0.0066
0.5048
Table 6
ANOVA analysis for pretest posttest visual analogue for 
intensity (I ).
Source
Group
Treat
Group*Treat
Time
ID(Group*Treat) 
Group*Time 
Treat*Time 
Group*Treat*Time 
Time*ID(Gr*Treat)
df SS
1 355746.12
2 340180.02
2 134397.25
1 11832.35
30 1549340.42
1 1770.12
2 2331.36
2 10130.25
30 158744.42
F PR > F
6.89 0.0131
3.29 0.0509
1.30 0.2871
2.24 0.1453
0.33 0.5673
2.20 0.1280
0.96 0.3954
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Table 7
ANOVA analysis for pretest posttest visual analogue for 
affect (A).
Source df SS F PR < F
Group 1 579426.12 10.79 0.0026
Treat 2 342492.69 3.19 0.0555
Group*Treat 2 80102.08 0.75 0.4831
Time 1 36315.12 6.84 0.0138
ID(Group*Treat) 30 1611566.12
Group*Time 1 13203.12 2.49 0.1253
Treat*Time 2 26202.58 2.47 0.1018
Group*Treat*Time 2 10651.08 1.00 0.3787
Time*ID(Gr*Treat) 30 159288.58
Table 8
ANOVA analysis for pretest posttest state anxiety 
(STAI).
Source df SS F PR > F
Group 1 107.55 2.62 0.1161
Treat 2 26.36 0.32 0.7280
Group*Treat 2 19.53 0.24 0.7899
Time 1 382.72 39.91 0.0001
ID(Group*Treat) 30 1232.33
Group*Time 1 0.05 0.01 0.9398
Treat*Time 2 12.19 0.64 0.5365
Group*Treat*Time 2 1.36 0.07 0.9316
Time*ID(Gr*Treat) 30 287.67
100
Table 9
ANOVA analysis for the pretest posttest confidence 
scales (CS).
Source df SS F PR > F
Group 1 22.22 20.20 0.0001
Treat 2 0.86 0.39 0.6795
Group*Treat 2 2.86 1.30 0.2873
Time 1 2.72 5.33 0.0281
ID(Group*Treat) 30 33.00
Group*Time 1 0.89 1.74 0.1972
Treat*Time 2 1.02 1.01 0.3779
Group*Treat*Time 2 1.02 1.01 0.3779
Time*ID(Gr*Treat) 30 15.33
Table 10
ANOVA analysis for the pretest posttest confidence 
analogues (CV).
Source df SS F PR > F
Group 1 38781.12 19.50 0.0001
Treat 2 3378.36 0.85 0.4376
Group*Treat 2 4388.58 1.10 0.3448
Time 1 7667.35 8.11 0.0079
ID(Group*Treat) 30 59651.00
Group*Time 1 3081.12 3.26 0.0810
Treat*Time 2 1287.53 0.68 0.5137
Group*Treat*Time 2 1620.08 0.86 0.4345
Time*ID(Gr*Treat) 30 28351.42
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Table 11
ANOVA analysis for the posttest relaxation 
levels (RE).
Source df SS F PR > F
Group 1 2080.12 2.29 0.1405
Treat 2 728.03 0.40 0.6731
Group*Treat 2 938.25 0.52 0.6015
Time 1 11125.35 25.41 0.0001
ID(Group*Treat) 30 27220.42
Group*Time 1 741.12 1.69 0.2031
Treat*Time 2 4052.03 4.63 0.0177
Group*Treat*Time 2 938.58 1.07 0.3551
Time*ID(Gr*Treat) 30 13134.42
Table 12
ANOVA analysis for the pretest posttest. time factor
(TM) .
Source df SS F PR > F
Group 1 58311.12 4.99 0.0331
Treat 2 64866.86 2.77 0.0784
Group*Treat 2 29359.75 1.26 0.2994
Time 1 1932.35 2.81 0.1043
ID(Group*Treat) 30 350716.08
Group*Time 1 1275.12 1.85 0.1837
Treat*Time 2 3711.36 2.70 0.0838
Group*Treat*Time 2 3003.58 2.18 0.1305
Time*ID(Gr*Treat) 30 20653.08
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Table 13
MANOVA analysis for single measure pain variables 
(MONT, BLUNT, EXPECT).
Source df F
Group 3, 28 2.93
Treat 6, 54 1.91
Group*Treat 6, 54 0.32
PR > F
0.0507
0.0954
0.9229
Table 14
ANOVA analysis for monitors (MONT).
Source
Group
Treat
Group*Treat 
ID(Group*Treat)
df SS
1 28.44
2 15.39
2 2.72
30 181.33
F PR > F
4.71 0.0381
1.27 0.2947
0.23 0.7977
Table 15
ANOVA analysis for blunters (BLUNT).
Source df SS
Group 1 0.44 0.10
Treat 2 20.39 2.25
Group*Treat 2 2.39 0.26
ID(Group*Treat) 30 135.67
Table 16
ANOVA analysis for expectancy (EXPECT).
Source df SS
Group 1 96.69 2.47
Treat 2 152.39 1.95
Group*Treat 2 53.72 0.69
ID(Group*Treat) 30 1174.17
PR > F
0.7561
0.1224
0.7696
PR > F
0.1265
0.1603
0.5112
104
Table 17
MANOVA analysis for heart Rate Data
Source df F PR > F
Group 6, 25 1.22 0.3302
Treat 12, 48 0.70 0.7402
Group*Treat 12, 48 0.78 0.6710
Time 5, 26 3.23 0.0213
Group*Time 5, 26 0.52 0.7577
Treat*TIme 10, 50 0.14 0.9991
Group*Treat*Time 10, 50 0.51 0.9891
Table 18
ANOVA analysis for low heart rate for pretreatment and 
posttreatment cold water pressor tests (C).
Source df SS F PR > F
Group 1 734.72 2.79 0.1053
Treat 2 587.53 1.12 0.3411
Group*Treat 2 750.03 1.42 0.2566
Time 1 180.50 11.81 0.0017
ID(Group*Treat) 30 7902.33
Group*Time 1 40.50 2.65 0.1141
Treat*TIme 2 13.58 0.44 0.6455
Group*Treat*Time 2 4.75 0.16 0.8568
Time*ID(Gr*Treat) 30 458.67
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Table 19
ANOVA analysis for high heart rate for pretreatment and 
posttreatment cold water pressor tests (CH).
Source df SS F PR > F
Group 1 1081.12 3.58 0.0682
Treat 2 610.53 1.01 0.3760
Group*Treat 2 568.75 0.94 0.4012
Time 1 171.12 17.24 0.0003
ID(Group*Treat) 30 9060.42
Group*Time 1 21.12 2.13 0.1550
Treat*TIme 2 0.25 0.01 0.9875
Group*Treat*Time 2 12.25 0.62 0.5462
Time*ID(Gr*Treat) 30 297.75
Table 20
ANOVA analysis for low heart rate during baseline phase 
(BASEL).
Source df SS PR > F
Group 1
Treat 2
Group*Treat 2
ID(Group*Treat) 30
280.05
481.33
1045.78
8646.33
0.97
0.84
1.81
0.3321
0.4437
0.1804
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Table 21
ANOVA analysis for high heart rate during baseline 
phase (BASEH).
Source df SS PR > F
Group 1
Treat 2
Group*Treat 2
ID(Group*Treat) 3 0
420.50 
321.78 
1024.00 
9094.33
1 .
0 ,
1 ,
39
53
69
0.2481
0.5936
0.2018
Table 22
ANOVA analysis for low heart rate during treatment 
phase (TXL).
Source df SS F PR > F
Group 1 612.50 3.49 0.0714
Treat 2 602.33 1.72 0.1968
Group*Treat 2 613.00 1.75 0.1915
ID(Group*Treat) 30 5261.67
Table 23
ANOVA analysis for high heart rate during treatment 
phase (TXH).
Source df SS F PR > F
Group
Treat
Group*Treat 
ID(Group*Treat)
1 734.72
2 533.33
2 716.44
30 6073.00
3.63 0.0664
1.32 0.2829
1.77 0.1877
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Table 24
Heart rate cell means, standard deviations and 
ranges (by athlete and treatment groups).
Group N C CH
1 36 6 6 .6 6 7 7 2 .9 7 2
2 36 7 3 .0 5 5 8 0 .7 2 2
T r e a t N C CH
1 24 6 8 .2 5 0 7 5 .0 0 0
2 24 6 7 .4 5 8 7 4 .5 8 3
3 24 7 3 .8 7 5 8 0 .9 5 8
BASEL BASEH TXL TXH
7 1 .4 4 4
7 5 .3 8 9
7 7 .4 4 4
8 2 .2 7 8
6 3 .1 6 7
6 9 .0 0 0
6 9 .0 5 5
7 5 .4 4 4
BASEL BASEH TXL TXH
7 2 .5 8 3
7 0 .7 5 0
7 6 .9 1 7
7 9 .0 8 3
7 7 .7 5 0
8 2 .7 5 0
6 6 .1 6 7
6 2 .5 0 0
6 9 .5 8 3
7 2 .2 5 0
6 8 .9 1 7
7 5 .5 8 3
GROUP TREAT BALM BAHH CWL1W CWH1M TLH THH CHL2H CWH2H BALSD
1 1 7 6 .0 8 2 .0 7 2 .8 7 6 .7 6 7 .2 7 3 .2 6 6 .3 7 3 .5 1 4 .3
1 2 6 6 .0 7 2 .7 6 3 .7 7 1 .0 5 6 .5 6 2 .2 5 9 .3 6 5 .8 1 1 .1
1 3 7 2 .3 7 7 .7 7 0 .5 7 7 .5 6 5 .8 7 1 .8 6 7 .3 7 3 .3 1 3 .1
2 1 6 9 .2 7 6 .2 6 8 .0 7 6 .3 6 5 .2 7 1 .3 6 5 .8 7 3 .5 8 .3
2 2 7 5 .5 8 2 .8 7 4 .2 8 1 .2 6 8 .5 7 5 .7 7 2 .7 8 0 .3 1 3 .3
2 3 8 1 .5 8 7 .8  ' 7 9 .5 B 7.7 7 3 .3 7 9 .3 7 8 .2 8 5 .3 1 1 .0
6R0UP TREAT BAHSD CWL1S0 CWH1SD TLSD THSD CNL25D CWH2SD BALHN
1 1 1 3 .3 1 1 .9 1 1 .9 1 0 .8 1 1 .2 9 .6 1 0 .3 6 3 .0
1 2 1 3 .7 1 1 .4 1 3 .3 8 .3 1 0 .0 1 3 .1 1 2 .8 5 3 .0
1 3 1 3 .2 1 1 .5 1 1 .1 8 .7 CD o 9 .0 9 .6 5 6 .0
2 1 8 .9 1 0 .3 9 .4 6 .6 6 .3 8 .4 7 .4 5 8 .0
2 2 1 2 .4 1 0 .6 9 .4 1 0 .1 1 1 .7 1 1 .2 1 2 .4 5 8 .0
2 3 1 1 .8 1 5 .6 1 7 .7 1 0 .8 1 1 .9 1 6 .2 1 9 .1 6 8 .0
GROUP TREAT BAHHN CHL1MN CWH1MN TLfIN THMN CWL2HN CWH2KN BALMX
1 1 7 1 .0 5 9 .0 6 8 ,0 5 4 .0 6 0 .0 5 5 .0 6 1 .0 9 8 .0
1 2 5 8 .0 4 8 .0 5 6 .0 4 7 .0 5 2 .0 4 6 .0 5 2 .0 8 1 .0
1 3 6 3 .0 5 9 .0 6 7 .0 5 5 .0 5 3 .0 5 7 .0 6 2 .0 9 5 .0
2 1 6 5 .0 5 8 .0 6 7 .0 5 6 .0 5 3 .0 5 8 .0 6 6 .0 8 0 .0
2 2 7 1 .0 5 9 .0 7 0 .0 5 7 .0 6 1 .0 5 7 .0 6 5 .0 9 8 .0
2 3 7 4 .0 6 1 .0 6 8 .0 5 8 .0 6 2 .0 5 9 .0 6 4 .0 9 6 .0
6R0UP TREAT BAHHX CWL1MX CWL2HX TLMX THHX CHL2HX CWH2HX
1 1 1 0 3 .0 8 7 .0 9 2 .0 8 2 .0 8 9 .0 8 1 .0 8 6 .0
1 2 9 3 .0 8 2 .0 9 5 .0 7 0 .0 8 0 .0 8 3 .0 8 8 .0
1 3 1 0 1 .0 9 1 .0 9 6 .0 8 1 .0 8 6 .0 7 9 .0 8 7 .0
2 1 9 0 .0 8 2 .0 9 1 .0 7 2 .0 8 0 .0 7 7 .0 8 4 .0
2 2 1 0 5 .0 8 9 .0 9 7 .0 8 5 .0 9 3 .0 8 8 .0 9 8 .0
2 3 1 0 4 .0 1 0 0 .0 1 1 0 .0 8 5 .0 9 3 .0 9 7 .0 1 0 8 .0
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Table 25
Cell means for each repeated heart rate variable 
(by Group*Time, Treat*Time, and Group*Treat*Time).
Group T is e N C CH BASEL BASEH TXL TXH
1 1 IB 6 9 .0 0 0 7 5 .0 5 6 7 1 .4 4 4 7 7 .4 4 4 6 3 .1 6 7 6 9 .0 5 5
1 2 IB 6 4 .3 3 3 7 0 .8B 9 7 1 .4 4 4 7 7 .4 4 4 6 3 .1 6 7 6 9 .0 5 5
2 1 18 73.BB 9 8 1 .7 2 2 7 5 .3 8 9 8 2 .2 7 8 6 9 .0 0 0 7 5 .4 4 4
2 2 IS 7 2 .2 2 2 7 9 .7 2 2 7 5 .3 8 9 8 2 .2 7 8 6 9 .0 0 0 7 5 .4 4 4
T r e a t T ia e N C CH BASEL BASEH TXL TXH
1 1 12 7 0 .4 1 7 7 6 .5 0 0 7 2 .5 8 3 7 9 .0 8 3 6 6 .1 6 7 7 2 .2 5 0
1 2 12 6 6 .0 8 3 7 3 .5 0 0 7 2 .5 8 3 7 9 .0 8 3 6 6 .1 6 7 7 2 .2 5 0
2 1 12 6 8 .9 1 7 76 .0B 3 7 0 .7 5 0 7 7 .7 5 0 6 2 .5 0 0 6 8 .9 1 7
2 2 12 6 6 .0 0 0 7 3 .0 8 3 7 0 .7 5 0 7 7 .7 5 0 6 2 .5 0 0 6 8 .9 1 7
3 1 12 7 5 .0 0 0 8 2 .5 8 3 7 6 .9 1 7 8 2 .7 5 0 6 9 .5 8 3 7 5 .5 8 3
3 2 12 7 2 .7 5 0 7 9 .3 3 3 7 6 .9 1 7 8 2 .7 5 0 6 9 .5 8 3 7 5 .5 8 3
6 ro u p T re a t Time N C CH BASEL BASEH TXL TXH
1 1 1 6 7 2 .8 3 3 7 6 .6 6 7 7 6 .0 0 0 ’ 8 2 .0 0 0 6 1 .1 6 7 7 3 .1 6 7
1 1 2 6 6 6 .3 3 3 7 3 .5 0 0 7 6 .0 0 0 8 2 .0 0 0 6 1 .1 6 7 7 3 .1 6 7
1 2 1 6 6 3 .6 6 7 7 1 .0 0 0 6 6 .0 0 0 7 2 .6 6 7 5 6 .5 0 0 6 2 .1 6 7
1 2 2 6 5 9 .3 3 3 6 5 .8 3 3 6 6 .0 0 0 7 2 .6 6 7 5 6 .5 0 0 6 2 .1 6 7
1 3 1 6 7 0 .5 0 0 7 7 .5 0 0 7 2 .3 3 3 7 7 .6 6 7 6 5 .8 3 3 7 1 .8 3 3
1 3 2 6 6 7 .3 3 3 7 3 .3 3 3 7 2 .3 3 3 7 7 .6 6 7 6 5 .8 3 3 7 1 .8 3 3
2 1 1 fa 6 8 .0 0 0 7 6 .3 3 3 6 9 .1 6 7 7 6 .1 6 7 6 5 .1 6 7 7 1 .3 3 3
2 1 2 fa 6 5 .6 3 3 7 3 .5 0 0 6 9 .1 6 7 7 6 .1 6 7 6 5 .1 6 7 7 1 .3 3 3
2 2 1 fa 7 4 .1 6 7 8 1 .1 6 7 7 5 .0 0 0 8 2 .3 3 3 6B .500 7 5 .6 6 7
2 2 2 fa 7 2 .6 6 7 8 0 .3 3 3 7 5 .0 0 0 8 2 .3 3 3 6 8 .5 0 0 7 5 .6 6 7
2 3 1 fa 7 9 .5 0 0 8 7 .6 6 7 8 1 .5 0 0 8 7 .8 3 3 7 3 .3 3 3 7 9 .3 3 3
2 3 2 fa 7 8 .1 6 7 8 5 .3 3 3 8 1 .5 0 0 8 7 .8 3 3 7 3 .3 3 3 7 9 .3 3 3
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Table 26
D a t a  s e t  f o r  a l l  h e a r t  r a t e  v a r i a b l e s .
TREAT BASEL BASEH CPH1 TXL TXH CPH2 C TIHE CPL1 CPL2 CH
1 65 72 68 54 60 67 81 1 81 59 68
1 65 72 68 54 60 67 59 2 81 59 67
1 63 71 70 64 69 69 66 1 66 64 70
1 63 71 70 64 69 69 64 2 66 64 69
1 98 103 92 82 89 86 82 1 82 74 92
1 98 103 92 82 89 B6 74 2 82 74 86
1 87 92 92 77 83 86 87 1 87 81 92
1 87 92 92 77 83 86 81 2 87 81 86
i 78 83 70 6B 74 72 62 1 62 65 70
1 78 83 70 68 74 72 65 2 62 65 72
1 65 71 68 58 64 61 59 1 59 55 68
1 65 71 68 58 64 61 55 2 59 55 61
2 81 93 95 70 80 88 82 1 B2 83 95
2 81 93 95 70 80 88 83 2 82 83 88
2 66 71 70 58 64 67 65 1 65 58 70
2 66 71 70 58 64 67 58 2 65 58 67
2 53 58 56 47 52 52 48 1 48 46 56
2 53 58 56 47 52 52 46 2 48 46 52
2 77 84 75 61 64 71 69 1 69 64 75
2 77 84 75 61 64 71 64 2 69 64 71
2 62 70 65 53 59 59 59 1 59 52 65
2 62 70 65 53 59 59 52 2 59 52 59
2 57 60 65 50 54 58 59 1 59 53 65
2 57 60 65 50 54 58 53 2 59 53 58
3 65 70 67 62 67 66 62 1 62 60 67
3 65 70 67 62 67 66 60 2 62 60 66
3 56 63 70 55 63 62 59 1 59 57 70
3 56 63 70 55 63 62 57 2 59 57 62
3 76 83 85 62 69 87 74 1 74 77 85
3 76 83 85 62 69 87 77 2 74 77 87
3 95 101 96 81 86 82 91 1 91 79 96
3 95 101 96 31 86 82 79 2 91 79 82
3 73 76 70 68 75 74 66 1 66 68 70
3 73 76 70 66 75 74 68 2 66 68 74
3 69 73 77 67 71 69 71 1 71 63 77
3 69 73 77 67 71 69 63 2 71 63 69
1 63 70 68 65 70 71 58 1 58 59 68
1 63 70 68 65 70 71 59 2 58 59 71
1 58 65 73 56 63 67 62 1 62 59 73
1 58 65 73 56 63 67 59 2 62 59 67
1 77 82 75 67 73 72 68 1 68 68 75
1 77 82 75 67 73 72 68 2 68 68 72
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
112
1 69 74 04 72 76 01 79 1 79 74 84
1 69 74 04 72 76 01 74 2 79 74 81
1 60 76 67 59 66 66 59 1 59 56 67
1 60 76 67 59 66 66 56 2 59 58 66
1 00 90 91 72 00 04 02 1 02 77 91
1 BO 90 91 72 00 64 77 2 62 77 84
2 60 72 75 57 61 65 70 1 70 57 75
2 60 72 75 57 61 65 57 2 70 57 65
2 79 07 02 72 00 66 76 1 76 78 02
2 79 07 02 72 00 60 70 2 76 78 68
2 50 71 70 59 64 66 59 1 59 63 70
2 50 71 70 59 64 66 63 2 59 63 68
2 74 00 70 67 77 79 69 1 69 72 78
2 74 00 70 67 77 79 72 2 69 72 79
2 90 105 97 05 73 90 09 1 09 88 97
2 90 105 97 05 93 90 06 2 09 88 98
2 76 02 05 71 79 64 02 1 02 78 85
2 76 02 05 71 79 04 70 2 82 78 84
3 75 79 03 69 73 79 70 1 70 75 83
3 75 79 63 69 73 79 75 2 78 75 79
3 96 104 103 05 93 100 90 1 90 97 103
3 96 104 103 05 93 106 97 2 90 97 106
3 60 74 60 50 62 64 61 1 61 59 68
3 60 74 60 50 62 64 59 2 61 59 64
3 09 96 94 70 06 09 66 1 06 80 94
3 09 96 94 70 06 09 60 2 66 80 89
3 73 00 60 66 73 66 62 1 62 62 68
3 73 00 60 66 73 66 62 2 62 62 66
3 00 94 110 04 09 106 100 1 100 96 110
3 00 94 110 04 09 106 96 2 100 96 106
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Table 27
Descriptive statistics for the entire group.
VARIABLE N MEAN STD DEV MINIMUM MAXIM
GROUP 36 1.500 0.507 1.000 2.000
TREAT 36 2.000 0.828 1.000 3.000
RELAX1 36 80.916 24.413 34.000 128.000
STAI1 36 15.750 4.662 6.000 24.000
C0NFS1 36 2.777 1.045 1.000 4.000
CONFV1 36 87.750 42.952 0.000 145.000
VASI1 36 445.416 190.877 85.000 750.000
VASA1 36 418.361 204.791 60.000 750.000
TIME1 36 256.972 91.027 25.000 306.000
MONT 36 10.055 2.552 5.000 15.000
BLUNT 36 4.444 2.131 1.000 9.000
RELAX2 36 105.778 28.771 30.000 145.000
CONFS2 36 3.167 1.035 1.000 4.000
CONFV2 36 108.389 46.589 0.000 145.000
STAI2 36 11.139 5.144 5.000 28.000
EXPECT 36 25.028 6.497 11.000 38.000
VAS12 36 419.778 192.608 57.000 750.000
VASA2 36 373.444 196.763 77.000 750.000
TIME2 36 267.333 83.130 26.000 300.000
Table 28
Descriptive statistics for athletes (treat 1 = humor, 
2 = relaxation, 3 = control).
GROUP=1 TREAT=1
VARIABLE N MEAN STD DEV MINIMUM MAXIM'
RELAX1 6 103.000 16.601 85.000 128.000
STAI1 6 13.333 5.007 8.000 21.000
C0NFS1 6 3.500 0.548 3.000 4.000
C0NFV1 6 111.000 21.503 82.000 132.000
VASI1 6 383.500 95.467 296.000 535.000
VASA1 6 323.833 104.949 186.000 509.000
TIME1 6 300.000 0.000 300.000 300.000
MONT 6 8.833 2.927 6.000 13.000
BLUNT 6 4.000 1.673 1.000 6.000
RELAX2 6 90.000 39.552 30.000 133.000
C0NFS2 6 3.667 0.516 3.000 4.000
C0NFV2 6 134.000 12.759 112.000 145.000
STAI2 6 9.333 2.065 7.000 13.000
EXPECT 6 29.000 7.536 18.000 38.000
VAS12 6 349.833 100.883 222.000 477.000
VASA2 6 284.544 109.859 146.000 440.000
TIME2 6 300.000 0.000 300.000 300.000
GR0UP=1 TREAT=2
VARIABLE N MEAN STD DEV MINIMUM MAXIM'
RELAX1 6 83.000 21.251 56.000 115.000
STAI1 6 15.667 6.889 6.000 24.000
CONFS1 6 3.167 0.983 2.000 4.000
CONFV1 6 120.000 27.568 79.000 145.000
VASI1 6 463.167 216.772 193.000 715.000
VASA1 6 395.333 268.424 97.000 733.000
TIME1 6 242.667 90.568 100.000 300.000
MONT 6 9.833 2.787 5.000 13.000
BLUNT 6 5.167 2.714 1.000 9.000
RELAX2 6 99.667 32.414 58.000 132.000
CONFS2 6 3.333 1.211 1.000 4.000
CONFV2 6 109.667 48.841 21.000 145.000
STAI2 6 11.833 7.083 5.000 24.000
EXPECT 6 23.333 4.412 19.000 29.000
VAS12 6 502.333 172.426 254.000 706.000
VASA2 6 427.333 193.103 194.000 707.000
TIME2 6 300.000 0.000 300.000 300.000
GR0UP=1 TREAT=3
VARIABLE N MEAN STD DEV MINIMUM MAXIM!
RELAX1 6 82.500 30.191 46.000 113.000
STAI1 6 14.667 3.724 10.000 20.000
C0NFS1 6 3.667 0.516 3.000 4.000
CONFV1 6 121.500 20.734 85.000 144.000
VASI1 6 263.833 139.969 85.000 453.000
VASA1 6 226.333 104.179 60.000 336.000
TIME1 6 300.000 0.000 300.000 300.000
MONT 6 8.833 1.835 6.000 11.000
BLUNT 6 3.833 1.941 1.000 7.000
RELAX2 6 126.167 13.761 109.000 145.000
CONFS2 6 3.833 0.408 3.000 4.000
CONFV2 6 131.500 19.419 94.000 145.000
STAI2 6 8.500 1.516 7.000 11.000
EXPECT 6 27.667 4.546 19.000 31.000
VAS12 6 211.167 123.634 57.000 347.000
VASA2 6 180.000 78.567 77.000 279.000
TIME2 6 300.000 0.000 300.000 300.000
Table 29
Descriptive statistics for non-athletes (treat 1 = 
humor, 2 = relaxation, 3 = control).
GR0UP=2 TREAT=1
VARIABLE N MEAN STD DEV MINIMUM MAXIM'
RELAX1 6 68.167 26.359 34.000 109.000
STAI1 6 16.500 4.549 9.000 21.000
C0NFS1 6 2.667 0.816 2.000 4.000
C0NFV1 6 81.833 38.426 41.000 133.000
VASI1 6 429.333 207.838 161.000 694.000
VASA1 6 424.667 165.581 197.000 624.000
TIME1 6 300.000 0.000 300.000 300.000
MONT 6 9.833 1.941 7.000 12.000
BLUNT 6 4.667 1.633 3.000 7 .000
RELAX2 6 96.333 27.976 65.000 140.000
CONFS2 6 2.667 0.516 2.000 3.000
C0NFV2 6 104.166 29.089 70.000 139.000
STAI2 6 12.000 5.404 5.000 18.000
EXPECT 6 22.333 8.359 11.000 34.000
VAS12 6 442.333 127.496 251.000 621.000
VASA2 6 398.333 101.097 234.000 511.000
TIME2 6 300.000 0.000 300.000 300.000
GR0UP=2 TREAT=2
VARIABLE N MEAN STD DEV MINIMUM MAXIM
RELAX1 6 67.333 17.040 49.000 95.000
STAI1 6 17.667 3.011 14.000 21.000
CONFS1 6 1.500 0.837 1.000 3.000
CONFV1 6 34.500 34.045 00.000 93.000
VASI1 6 548.667 147.575 413.000 750.000
VASA1 6 544.667 164.544 318.000 750.000
TIME1 6 218.333 127.932 25.000 300.000
MONT 6 11.000 2.757 8.000 15.000
BLUNT 6 3.333 2.422 1.000 7.000
RELAX2 6 115.333 27.926 64.000 144.000
CONFS2 6 2.667 1.367 1.000 4.000
CONFV2 6 84.167 63.464 00.000 141.000
STAI2 6 12.330 7.967 5.000 28.000
EXPECT 6 26.667 6.218 15.000 32.000
VAS12 6 450.667 229.688 257.000 750.000
VASA2 6 397.833 237.215 213.000 750.000
TIME2 6 220.167 125.587 26.000 300.000
GR0UP=2 TREAT=3
VARIABLE N MEAN STD DEV MINIMUM MAXIM'
RELAX1 6 81.500 22.349 54.000 117.000
STAI1 6 16.667 4.633 11.000 24.000
C0NFS1 6 2.167 0.753 1.000 3.000
CONFV1 6 57.667 31.039 15.000 94.000
VASI1 6 584.000 183.507 293.000 750.000
VASA1 6 595.500 180.651 311.000 750.000
TIME1 6 179.833 132.222 37.000 300.000
MONT 6 12.000 2.280 9.000 15.000
BLUNT 6 5.667 2.160 3.000 8.000
RELAX2 6 99.167 23.284 55.000 121.000
CONFS2 6 2.833 1.471 1.000 4.000
CONFV2 6 86.833 68.420 00.000 145.000
STAI2 6 12.833 4.119 8.000 20.000
EXPECT 6 21.167 5.419 16.000 28.000
VAS12 6 562.333 207.537 250.000 750.000
VASA2 6 552.667 226.061 224.000 750.000
TIME2 6 183.833 128.233 39.000 300.000
Appendix N 
Pearson Moment Correlations
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Table 30
Correlation matrix for the entire group.
RELAX1 STAI1 CDNFS1 C0NFV1 VAS11 VASA1 TII1E1 NONT
RELAX1 1 .0 0 0 - 0 .6 5 8 0 .4 8 2 - 0 .4 8 4 - 0 .2 0 4 - 0 .2 7 3 0 .1 2 2 0 .0 3 9
0 .0 0 0 0 0 .0 0 0 1 0 .0 0 2 8 0 .0 0 0 2 0 .2 3 3 6 0 .1 0 7 2 0 .4 7 8 4 0 .8 2 3 1
STAI1 -0 .6 5 B 1 .0 0 0 - 0 .5 2 8 -0 .4 8 1 0 .3 4 0 0 .5 1 7 -0 .3 2 7 0 .1 6 9
0 .0 0 0 1 0 .0 0 0 0 0 .0 0 0 9 0 .0 0 3 0 0 .0 4 2 3 0 .0 0 1 2 0 .0 5 1 3 0 .3 2 3 5
C0NFS1 0 .4 8 2 - 0 .5 2 8 1 .0 0 0 0 .9 0 1 - 0 .5 3 5 - 0 .6 2 4 0 .5 1 1 - 0 .2 7 4
0 .0 0 2 9 0 .0 0 0 9 0 .0 0 0 0 0 .0 0 0 1 O.OOOB 0 .0 0 0 1 0 .0 0 1 4 0 .1 0 6 1
CQNFV1 0 .4 8 4 -0 .4 8 1 0 .9 0 1 1 ,0 0 0 - 0 .4 9 5 -0 .5 7 1 0 .3 5 2 - 0 .1 9 3
0 .0 0 2 8 0 .0 0 3 0 0 .0 0 0 1 0 .0 0 0 0 0 .0 0 2 2 0 .0 0 0 3 0 .0 3 4 9 0 .2 6 0 0
VASil - 0 .2 0 4 0 .3 4 0 - 0 .5 3 5 - 0 .4 9 5 1 .0 0 0 0 .8 6 5 - 0 .7 0 7 0 .2 6 5
0 .2 2 3 6 0 .0 4 2 3 O.OOOB 0 .0 0 2 2 0 .0 0 0 0 0 .0 0 0 1 0 .0 0 0 1 0 .1 1 7 9
VASA1 - 0 .2 7 3 0 .5 1 7 - 0 .6 2 4 -0 .5 7 1 0 .8 6 5 1 .0 0 0 - 0 .7 3 3 0 .3 7 9
0 .1 0 7 2 0 .0 0 1 2 0 .0 0 0 1 0 .0 0 0 3 0 .0 0 0 1 0 .0 0 0 0 0 .0 0 0 1 0 .0 2 2 5
TIME1 0 .1 2 2 - 0 .3 2 7 0 .5 1 1 0 .3 5 2 - 0 .7 0 7 - 0 .7 3 3 1 .0 0 0 - 0 .0 9 3
0 .4 7 8 4 0 .0 5 1 3 0 .0 0 1 4 0 .0 3 4 9 0 .0 0 0 1 0 .0 0 0 1 0 .0 0 0 0 0 .5 8 9 1
MONT 0 .0 3 9 0 .1 6 7 -0 .2 7 4 - 0 .1 9 3 0 .2 6 5 0 .3 7 9 - 0 .0 9 3 1 .0 0 0
0.B 231 0 .3 2 3 5 0 .1 0 6 1 0 .2 6 0 0 0 .1 1 7 9 0 .0 2 2 5 0 .5 8 9 1 0 .0 0 0 0
BLUNT -0 .0 6 1 0 .1 8 4 - 0 .1 0 8 -0 .1 2 9 - 0 .0 0 5 0 .0 2 3 0 .0 5 0 0 .1 1 1
0 .7 2 4 7 0 .2 8 2 5 0 .5 2 9 3 0 .4 5 3 6 0 .9 7 6 8 0 .3 9 1 7 0 .7 7 0 1 0 .5 1 9 5
RELAX2 0 .2 4 6 - 0 .5 7 5 0 .2 6 6 0 .2 3 4 - 0 .3 0 4 - 0 .4 1 3 0 .2 8 8 0 .0 0 8
0 .1 4 7 9 0 .0 0 0 2 0 .1 1 6 5 0 .1 7 0 0 0 .0 7 1 5 0 .0 1 2 2 0 .0 8 8 3 0 .9 6 1 5
C0NFS2 0 .2 3 2 -0 .3 9 2 0 .5 2 7 0 .4 9 3 - 0 .6 1 4 -0 .6 5 1 0 .7 2 8 - 0 .0 5 6
0 .1 7 2 8 0 .0 1 8 1 0 .0 0 1 0 0 .0 0 2 2 0 .0 0 0 1 0 .0 0 0 1 0 .0 0 0 1 0 .7 4 3 1
C0NFV2 0 .2 6 1 -0 .4 3 2 0 .5 4 2 0 .5 1 3 - 0 .6 3 3 - 0 .6 8 9 0 .8 0 4 - 0 .0 1 2
0 .1 2 4 4 0 .0 0 8 4 0 .0 0 0 6 0 .0 0 1 4 0 .0 0 0 1 0 .0 0 0 1 0 .0 0 0 1 0 .9 4 3 7
STAI2 - 0 .3 9 9 0 .6 4 6 -0 .3 5 5 - 0 .2 8 6 0 .3 9 8 0 .5 5 6 - 0 .4 4 9 0 .0 8 2
0 .015B 0 .0 0 0 1 0 .0 3 3 4 0 .0 9 1 0 0 .0 1 6 2 0 .0 0 0 4 0 .0 0 6 0 0 .6 3 4 0
EXPECT 0 .3 0 7 -0 .3 3 1 0 .1 8 6 0 .2 1 7 - 0 .3 1 9 - 0 .3 4 1 0 .3 2 7 0 .0 5 5
0 .0 6 8 6 0 .0 4 8 7 0 .2 2 7 1 0 .2 0 2 5 0 .0 5 8 1 0 .0 4 1 7 0 .0 5 1 4 0 .7 4 9 8
VAS12 - 0 .2 9 2 0 .3 5 2 - 0 .4 4 6 - 0 .3 8 2 0 .8 4 9 0 .7 1 8 - 0 .6 7 9 0 .1 4 3
0 .8 5 3 8 0 .0 3 5 5 0 .0 0 6 4 0 .0 2 1 6 0 .0 0 0 1 0 .0 0 0 1 0 .0 0 0 1 0 .4 0 4 9
VASA2 - 0 .3 3 2 0 .4 9 9 - 0 .5 2 3 -0 .4 3 3 0 .8 0 8 0 .8 5 2 -0 .7 8 1 0 .1 8 2
0 .0 4 8 0 0 .0 0 1 9 0 .0 0 1 1 0 .0 0 8 3 0 .0 0 0 1 0 .0 0 0 1 0 .0 0 0 1 0 .2 8 8 1
T1ME2 0 .1 1 2 - 0 .2 6 4 0 .4 5 6 0 .3 7 1 - 0 .6 1 1 - 0 .6 2 9 0 .6 9 6 - 0 .0 5 0
0 .5 1 4 5 0 .1 2 0 3 0 .0 0 5 1 0 .0 2 5 8 0 .0 0 0 1 0 .0 0 0 1 0 .0 0 0 1 0 .7 7 1 3
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BLUNT RELAX2 C0NFS2 C0NFV2
RELAX1 -0 .0 6 1 0 .2 4 6 0 .2 3 2 0 .2 6 1
0 .7 2 4 7 0 .1 4 7 9 0 .1 7 2 8 0 .1 2 4 4
STAU 0 .1B 4 - 0 .5 7 5 - 0 .3 9 2 - 0 .4 3 2
0 .2 8 2 5 0 .0 0 0 2 0 .0 1 8 1 0 .0 0 8 4
C0NFS1 - 0 .1 0 8 0 .2 6 6 0 .5 2 7 0 .5 4 2
0 .5 2 9 3 0 .1 1 6 5 0 .0 0 1 0 0 .0 0 0 6
CQNFV1 - 0 .1 2 9 0 .2 3 4 0 .4 9 3 0 .5 1 3
0 .4 5 3 6 0 .1 7 0 0 0 .0 0 2 2 0 .0 0 1 4
VASI1 - 0 .0 0 5 - 0 .3 0 4 - 0 .6 1 4 - 0 .6 3 3
0 .9 7 6 8 0 .0 7 1 5 0 .0 0 0 1 0 .0 0 0 1
VASA1 0 .0 2 3 - 0 .4 1 3 -0 .6 5 1 - 0 .6 8 9
0 .8 9 1 7 0 .0 1 2 2 0 .0 0 0 1 0 .0 0 0 1
TIME1 0 .0 5 0 0 .2 8 8 0 .7 2 8 0 .9 0 4
0 .7 7 0 1 0 .0 8 8 3 0 .0 0 0 1 0 .0 0 0 1
HONT 0 .1 1 1 0 .0 0 8 - 0 .0 5 6 - 0 .0 1 2
0 .5 1 9 5 0 .9 6 1 5 0 .7 4 3 1 0 .9 4 3 7
BLUNT 1 .0 0 0 - 0 .2 0 8 - 0 .0 9 5 -0 .0 B 2
0 .0 0 0 0 0 .2 2 2 2 0 .6 2 3 4 0 .6 3 2 9
RELAX2 -0 .2 0 B 1 .0 0 0 0 .3 7 7 0 .3 8 4
0 .2 2 2 2 0 .0 0 0 0 0 .0 2 3 6 0 .0 2 0 6
CQNFS2 - 0 .0 8 5 0 .3 7 7 1 .0 0 0 0 .9 4 9
0 .6 2 3 4 0 .0 2 3 6 0 .0 0 0 0 0 .0 0 0 1
CQNFV2 - 0 .0 8 2 0 .3 8 4 0 .9 4 9 1 .0 0 0
0 .6 3 2 9 0 .0 2 0 6 0 .0 0 0 1 0 .0 0 0 0
STAI2 0 .1 1 9 - 0 .7 3 9 -0 .4 6 2 - 0 .5 4 2
0 .4 8 8 2 0 .0 0 0 1 0 .0 0 4 6 0 .0 0 0 6
EXPECT - 0 .1 0 8 0 .4 0 4 0 .4 1 2 0 .4 4 7
0 .5 2 9 7 0 .0 1 4 6 0 .0 1 2 6 0 .0 0 6 2
VAS12 0 .0 2 6 - 0 .3 2 2 - 0 .6 5 0 - 0 .6 6 9
0 .8 8 1 3 0 .0 5 5 8 0 .0 0 0 1 0 .0 0 0 1
VASA2 0 .1 1 5 -0 .4 6 1 - 0 .7 3 4 - 0 .7 6 2
0 .5 0 5 6 0 .0 0 4 7 0 .0 0 0 1 0 .0 0 0 1
TIME2 0 .1 4 9 0 .1 9 9 0 .6 5 9 0 .7 3 0
0 .3 8 6 3 0 .2 4 4 3 0 .0 0 0 1 0 .0 0 0 1
STAI2 EXPECT VASI2 VASA2 riME2
- 0 .3 9 9 0 .3 0 7 - 0 .2 9 2 -0 .3 3 1  0 .1 1 2
0 .0 1 5 3 0 .0 6 8 6 0 .0 8 3 8 0 .0 4 8 0 0 .5 1 4 5
0 .6 4 6 -0 .3 3 1 0 .3 5 2 0 .4 9 9 - 0 .2 6 4
0 .0 0 0 1 0 .0 4 8 7 0 .0 3 5 5 0 .0 0 1 9 0 .1 2 0 3
- 0 .3 5 5 0 .1 8 6 - 0 .4 4 6 - 0 .5 2 3 0 .4 5 6
0 .0 3 3 4 0 .2 7 7 1 0 .0 0 6 4 0 .0 0 1 1 0 .0 0 5 1
- 0 .2 8 6 0 .2 1 7 - 0 .3 8 2 - 0 .4 3 3 0 .3 7 1
0 .0 9 1 0 0 .2 0 2 5 0 .0 2 1 6 0 .0 0 8 3 0 .0 2 5 8
0 .39B - 0 .3 1 9 0 .8 4 9 0 .8 0 8 - 0 .6 1 2
0 .0 1 6 2 0 .0 5 8 1 0 .0 0 0 1 0 .0 0 0 1 0 .0 0 0 1
0 .5 5 6 -0 .3 4 1 0 .7 1 7 0 .3 5 2 - 0 .6 2 9
0 .0 0 0 4 0 .0 4 1 7 0 .0 0 0 1 0 .0 0 0 1 0 .0 0 0 1
- 0 .4 4 9 0 .3 2 7 - 0 .6 7 9 - 0 .7 8 1 0 .8 9 6
0 .0 0 6 0 0 .0 5 1 4 0 .0 0 0 1 0 .0 0 0 1 0 .0 0 0 1
0 .0 8 2 0 .0 5 5 0 .1 4 3 0 .1 8 2 -0 .0 5 0
0 .6 3 4 0 0 .7 4 9 8 0 .4 0 4 9 0 .2 8 8 1 0 .7 7 1 3
0 .1 1 9 - 0 .1 0 8 0 .0 2 6 0 .1 1 5 0 .1 4 9
0 .4 8 8 2 0 .5 2 9 7 0 .8 8 1 3 0 .5 0 5 6 0 .3 8 6 3
- 0 .7 3 9 0 .4 0 4 - 0 .3 2 2 - 0 .4 6 1 0 .1 9 9
0 .0 0 0 1 0 .0 1 4 6 0 .0 5 5 8 0 .0 0 4 7 0 .2 4 4 3
-0 .4 6 2 0 .4 1 2 - 0 .6 5 0 - 0 .7 3 4 0 .6 5 9
0 .0 0 4 1 0 .0 1 2 6 0 .0 0 0 1 0 .0 0 0 1 0 .0 0 0 1
- 0 .5 4 2 0 .4 4 7 - 0 .6 6 9 - 0 .7 6 2 0 .7 3 0
0 .0 0 0 6 0 .0 0 6 2 0 .0 0 0 1 0 .0 0 0 1 0 .0 0 0 1
1 .0 0 0 -0 .3 5 1 0 .4 4 7 0 .5 9 9 - 0 .4 2 6
0 .0 0 0 0 0 .0 3 6 0 0 .0 0 4 1 0 .0 0 0 1 0 .0 0 9 5
- 0 .3 5 1 1 .0 0 0 - 0 .5 2 2 - 0 .5 5 6 0 .3 5 4
0 .0 3 6 0 0 .0 0 0 0 0 .0 0 1 1 0 .0 0 0 4 0 .0 3 4 1
0 .4 6 7 - 0 .5 2 2 1 .0 0 0 0 .9 1 8 -0 .6 6 1
0 .0 0 4 1 0 .0 0 1 1 0 .0 0 0 0 0 .0 0 0 1 0 .0 0 0 1
0 .5 9 9 - 0 .5 5 6 0 .9 1 8 1 .0 0 0 -0 .7 2 1
0 .0 0 0 1 0 .0 0 0 4 0 .0 0 0 1 0 .0 0 0 0 0 .0 0 0 1
- 0 .4 2 6 0 .3 5 4 - 0 .6 6 1 -0 .7 2 1 1 .0 0 0
0 .0 0 9 5 0 .0 3 4 1 0 .0 0 0 1 0 .0 0 0 1 0 .0 0 0 0
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Table 31
C o r r e l a t i o n  m a t r i x  f o r  a t h l e t e s  i n  h u m o r  t r e a t m e n t .
RELAX1 STA11 CDNFS1 C0NFV1 VASI1 VASA1 T1ME1 MONT
RELAX1 1 .0 0 0 - 0 .8 2 0 0 .6 8 2 0 .8 3 9 0 .0 9 1 - 0 .2 9 2 0 .0 0 0 0 .1 3 2
0 .0 0 0 0 0 .0 4 5 4 0 .1 3 5 7 0 .0 3 6 7 0 .8 6 3 5 0 .5 7 4 7 1 .0 0 0 0 0 .6 0 3 6
S T ftll - 0 .8 2 0 1 .0 0 0 - 0 .8 7 5 - 0 .9 7 3 - 0 .5 2 4 - 0 .0 7 8 0 .0 0 0 - 0 .0 6 4
0 .0 4 5 4 0 .0 0 0 0 0 .0 2 2 4 0 .0 0 1 0 0 .2 8 6 1 0 .8 8 3 4 1 .0 0 0 0 0 .9 0 4 6
CQNFS1 0 .6 B 2 - 0 .8 7 5 1 . 000 0 .8 4 9 0 .5 7 9 0 .1 7 6 0 .0 0 0 - 0 .1 8 7
0 .1 3 5 7 0 .0 2 2 4 0 .0 0 0 0 0 .0 3 2 5 0 .2 2 8 1 0 .7 3 9 2 1 .0 0 0 0 0 .7 2 2 6
C0NFV1 0 .8 3 9 - 0 .9 7 3 0 .8 4 9 1 .0 0 0 0 .5 8 9 0 .1 0 1 0 .0 0 0 0 .1 8 4
0 .0 3 6 7 0 .0 0 1 0 0 .0 3 2 5 0 .0 0 0 0 0 .2 1 8 1 0 .8 4 8 9 1 .0 0 0 0 0 .7 2 6 7
VflSU 0 .0 9 1 - 0 .5 2 4 0 .5 7 9 0 .5 8 9 1 .0 0 0 0 .4 7 9 0 .0 0 0 0 .2 8 5
0 .8 6 3 5 0 .2 8 6 1 0 .2 2 8 1 0 .2 1 8 1 0 .0 0 0 0 0 .3 3 5 9 1 .0 0 0 0 0 .5 8 3 8
VASA1 - 0 .2 9 2 - 0 .0 7 8 0 .1 7 6 0 .1 0 1 0 .4 7 9 1 .0 0 0 0 .0 0 0 - 0 .4 5 9
0 .5 7 4 7 0 .8 8 3 4 0 .7 3 9 2 0 .8 4 8 8 0 .3 3 5 9 0 .0 0 0 0 1 .0 0 0 0 0 .3 5 8 9
TIME! 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0
1 .0 0 0 0 1 .0 0 0 0 I . 0000 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0
MONT 0 .1 3 2 - 0 .0 6 4 -0 .1 8 7 0 .1 8 4 0 .2 8 5 - 0 .4 5 9 0 .0 0 0 1 .0 0 0
0 .8 0 3 6 0 .9 0 4 6 0 .7 2 2 6 0 .7 2 6 7 0 .5 8 3 8 0 .3 5 8 9 1 .0 0 0 0 0 .0 0 0 0
BLUNT - 0 .6 5 5 0 .6 6 8 - 0 .6 5 5 - 0 .7 2 8 -0 .5 5 1 0 .3 9 1 0 .0 0 0 - 0 .5 7 2
0 .1 5 7 9 0 .1 4 6 7 0 .1 5 8 3 0 .1 0 0 8 0 .2 5 7 3 0 .4 4 3 9 1 .0 0 0 0 0 .2 3 5 9
RELAX2 0 .6 2 7 - 0 .9 4 5 0 .7 9 4 0 .9 3 0 0 .7 2 4 0 .1 9 4 0 .0 0 0 0 .2 1 2
0 .1 8 2 9 0 .0 0 4 0 0 .0 5 9 3 0 .0 0 7 1 0 .1 0 3 5 0 .7 1 2 8 1 .0 0 0 0 0 .6 8 6 1
C0NFS2 0 .3 0 3 - 0 .6 4 5 0 .7 0 7 0 .4 6 8 0 .2 7 9 0 .1 2 8 0 .0 0 0 -0 .4 4 1
0 .5 5 9 0 0 .1 6 7 0 0 .1 1 6 1 0 .3 4 8 9 0 .5 9 1 1 0 .8 0 9 1 1 .0 0 0 0 0 .3 8 1 3
CQNFV2 0 .4 5 1 -0 .8 3 9 0 .7 7 3 0 .7 1 5 0 .4 8 4 0 .3 0 1 0 .0 0 0 - 0 .2 6 8
0 .3 6 9 0 0 .0 3 6 8 0 .0 7 1 6 0 .1 1 0 2 0 .3 3 1 0 0 .5 6 2 2 1 .0 0 0 0 0 .6 0 7 9
STAI2 - 0 .8 6 9 0 .7 2 2 -0 .7 0 7 - 0 .8 3 3 - 0 .3 6 0 0 .0 2 7 0 .0 0 0 - 0 .1 8 7
0 .0 2 4 6 0 .1 0 5 2 0 .1 1 6 1 0 .0 3 9 5 0 .4 8 3 3 0 .9 5 9 4 1 .0 0 0 0 0 .7 2 2 1
EXPECT 0 .2 7 0 - 0 .4 9 3 0 .4 3 6 0 .6 4 5 0 .8 5 8 0 .4 5 1 0 .0 0 0 0 .4 4 4
0 .6 0 4 6 0 .3 2 0 5 0 .3 8 7 4 0 .1 6 6 3 0 .0 2 8 7 0 .3 6 9 8 1 .0 0 0 0 0 .3 7 7 4
VAS12 - 0 .1 2 7 -0 .2 6 7 0 .2 7 3 0 .3 5 4 0 .9 2 5 0 .3 1 4 0 .0 0 0 0 .5 3 8
0 .8 0 9 9 0 .6 0 8 8 0 .6 0 0 3 0 .4 9 1 3 0 .0 0 8 1 0 .5 4 4 9 1 .0 0 0 0 0 .2 7 0 5
VASA2 -0 .7 0 7 0 .4 1 3 - 0 .3 1 4 - 0 .3 3 7 0 .3 7 8 0 .6 0 5 0 .0 0 0 - 0 .1 2 2
0 .1 1 5 9 0 .4 1 5 2 0 .5 4 4 3 0 .5 1 3 7 0 .4 6 0 2 0 .5 1 3 1 1 .0 0 0 0 0 .8 1 6 7
TIME2 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0
1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0
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BLUNT RELAX2 C0NFS2 CQNFV2
RELAX 1 -0 .6 5 5 0 .6 2 7 0 .3 0 3 0 .4 5 1
0 .1 5 7 9 0 .1 8 2 9 0 .5 5 9 0 0 .3 6 9 0
STAU 0 .6 6 8 - 0 .9 4 5 - 0 .6 4 5 - 0 .8 3 9
0 .1 4 6 7 0 .0 0 4 4 0 .1 6 7 0 0 .0 3 6 8
C0NFS1 - 0 .6 5 5 0 .7 9 4 0 .7 0 7 0 .7 7 3
•i 0 .1 5 6 3 0 .0 5 9 3 0 .1 1 6 1 0 .0 7 1 6
CQNFV1 - 0 .7 2 8 0 .9 3 0 0 .4 6 8 0 .7 1 5
0 .1 0 0 8 0 .0 0 7 1 0 .3 4 8 9 0 .1 1 0 2
VASU -0 .5 5 1 0 .7 2 4 0 .2 7 9 0 .4 8 3
0 .2 5 7 3 0 .1 0 3 5 0 .5 9 1 1 0 .3 3 1 0
VASA1 0 .3 9 1 0 .1 9 3 0 .1 2 8 0 .3 0 1
0 .4 4 3 9 0 .7 1 2 8 0 .8 0 9 1 0 .5 6 2 2
TIME1 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0
1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0
HONT -0 .5 7 1 0 .2 1 2 -0 .4 4 1 - 0 .2 6 8
0 .2 3 5 9 0 .6 8 6 1 0 .3 8 1 3 0 .6 0 7 9
BLUNT 1 .0 0 0 - 0 .6 6 8 - 0 .2 3 1 - 0 .3 1 8
0 .0 0 0 0 0 .1 4 7 2 0 .6 5 9 0 0 .5 3 8 4
RELAX2 -0 .6 6 8 1 .0 0 0 0 .6 0 7 0 .8 4 3
0 .1 4 7 2 0 .0 0 0 0 0 .2 0 1 2 0 .0 3 5 1
C0NFS2 -0 .2 3 1 0 .6 0 7 1 .0 0 0 0 .9 1 2
0 .6 5 9 0 0 .2 0 1 2 0 .0 0 0 0 0 .0 1 1 6
CONFV2 - 0 .3 1 8 0 .8 4 3 0 .9 1 1 1 .0 0 0
0 .5 3 8 4 0 .0 3 5 1 0 .0 1 1 6 0 .0 0 0 0
STAI2 0 .6 9 4 - 0 .5 8 5 - 0 .0 6 2 - 0 .2 7 3
0 .1 2 5 8 0 .2 2 2 5 0 .9 0 6 4 0 .6 0 0 4
EXPECT - 0 .5 2 3 0 .6 4 1 - 0 .1 0 3 0 .2 3 3
0 .2 8 6 6 0 .1 7 0 4 0 .8 4 6 4 0 .6 5 6 9
VAS12 - 0 .5 0 8 0 .5 3 5 0 .0 3 7 0 .2 2 1
0 .3 0 3 3 0 .2 7 4 4 0 .9 4 4 4 0 .6 7 4 2
VASA2 0 .4 9 4 - 0 .1 9 5 - 0 .3 2 4 - 0 .2 0 4
0 .3 1 9 4 0 .7 1 0 7 0 .5 3 0 6 0 .6 9 7 6
TIME2 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0
1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0
STA12 EXPECT VASI2 VASA2 TINE2
- 0 .8 6 9 0 .2 7 0 -0 .1 2 7 - 0 .7 0 7 0 .0 0 0
0 .0 2 4 6 0 .6 0 4 6 0 .8 0 9 9 0 .1 1 5 9 0 .1 0 0 0
0 .7 2 2 - 0 .4 9 3 -0 .2 6 7 0 .4 1 3 0 .0 0 0
0 .1 0 5 2 0 .3 2 0 5 0 .6 0 8 8 0 .4 1 5 2 1 .0 0 0 0
- 0 .7 0 7 0 .4 3 6 0 .2 7 3 -0 .3 1 4 0 .0 0 0
0 .1 1 6 1 0 .3 8 7 4 0 .6 0 0 3 0 .5 4 4 3 1 .0 0 0 0
- 0 .8 3 3 0 .6 4 5 0 .3 3 3 -0 .3 3 7 0 .0 0 0
0 .0 3 9 5 0 .1 6 6 3 0 .4 9 1 3 0 .5 1 3 7 1 .0 0 0 0
- 0 .3 6 0 0 .8 5 8 0 .9 2 5 0 .3 7 8 0 .0 0 0
0 .4 8 3 3 0 .0 2 8 7 0 .0 0 8 1 0 .4 6 0 2 1 .0 0 0 0
0 .0 2 7 0 .4 5 1 0 .3 1 4 0 .8 0 5 0 .0 0 0
0 .9 5 9 4 0 .3 6 9 8 0 .5 4 4 9 0 .0 5 3 1 1 .0 0 0 0
0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0
1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0
- 0 .1 8 7 0 .4 4 4 0 .5 3 8 -0 .1 2 2 0 .0 0 0
0 .7 2 2 1 0 .3 7 7 4 0 .2 7 0 5 0 .8 1 7 6 1 .0 0 0 0
0 .6 9 4 - 0 .5 2 3 0 .5 0 8 0 .4 9 4 0 .0 0 0
0 .1 2 5 8 0 .2 8 6 6 0 .3 0 3 3 0 .3 1 9 4 1 .0 0 0 0
- 0 .5 8 5 0 .6 4 1 0 .5 3 5 -0 .1 9 5 0 .0 0 0
0 .2 2 2 5 0 .1 7 0 4 0 .2 7 4 4 0 .7 1 0 7 1 .0 0 0 0
- 0 .0 6 2 - 0 .1 0 3 0 .0 3 7 - 0 .3 2 4 0 .0 0 0
0 .9 0 6 4 0 .8 4 6 4 0 .9 4 4 4 0 .5 3 0 6 1 .0 0 0 0
- 0 .2 7 3 0 .2 3 3 0 .2 2 1 - 0 .2 0 4 0 .0 0 0
0 .6 0 0 4 0 .6 5 6 9 0 .6 7 4 2 0 .6 9 7 6 1 .0 0 0 0
1 .0 0 0 - 0 .6 0 4 -0 .1 4 6 0 .3 5 7 0 .0 0 0
0 .0 0 0 0 0 .2 0 4 3 0 .7 8 1 8 0 .4 8 7 3 1 .0 0 0 0
- 0 .6 0 4 1 .0 0 0 0 .7 9 8 0 .3 7 7 0 .0 0 0
0 .2 0 4 3 0 .0 0 0 0 0 .0 5 6 9 0 .4 6 1 5 1 .0 0 0 0
- 0 .1 4 6 0 .7 9 8 1 .0 0 0 0 .4 4 1 0 .0 0 0
0 .7 8 1 8 0 .0 5 6 9 0 .0 0 0 0 0 .3 8 0 7 1 .0 0 0 0
0 .3 5 7 0 .3 7 7 0 .4 4 1 1 .0 0 0 0 .0 0 0
0 .4 8 7 3 0 .4 6 1 5 0 .3 8 0 7 0 .0 0 0 0 1 .0 0 0 0 0
0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0
1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0
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Table 32
Correlation matrix for athletes in relaxation treatment.
RELAX1 STAI1 C0NFS1 C0NFV1 VASU VASA1 TIME1 MONT
RELAX1 1 .0 0 0 - 0 .8 2 9 0 .1 2 8 0 .7 2 5 -0 .1 9 4 - 0 .4 4 9 0 .3 0 1 0 .4 6 0
0 .0 0 0 0 0 .0 4 1 4 0 .3 0 8 6 0 .1 0 3 0 0 .7 1 2 8 0 .3 7 1 0 0 .5 6 3 2 0 .3 5 8 3
STAI1 - 0 .8 2 9 1 .0 0 0 0 .1 3 9 - 0 .5 4 9 - 0 .2 5 5 -0 .0 4 6 0 .4 8 2 - 0 .7 7 1
0 .0 4 1 4 0 .0 0 0 0 0 .7 9 3 3 0 .2 5 9 1 0 .6 2 9 5 0 .9 3 1 5 0 .3 3 2 6 0 .0 7 2 8
C0NF51 0 .1 2 9 0 .1 3 9 1 .0 0 0 0 .7 0 9 -0 .5 1 3 - 0 .4 6 7 - 0 .6 3 2 - 0 .0 7 0
0 .B 086 0 .7 9 3 3 0 .0 0 0 0 0 .1 1 1 4 0 .2 9 8 2 0 .3 5 0 2 0 .1 7 7 8 0 .8 9 4 6
C0NFV1 0 .7 2 5 - 0 .5 4 9 0 .7 0 9 1 .0 0 0 - 0 .2 1 7 - 0 .3 6 7 - 0 .0 3 5 0 .4 0 7
0 .1 0 3 0 0 .2 5 9 1 0 .1 1 4 1 0 .0 0 0 0 0 .6 7 9 6 0 .4 7 3 9 0 .9 4 6 9 0 .4 2 2 7
VASU -0 .1 9 4 - 0 .2 5 5 - 0 .5 1 3 -0 .2 1 7 1 .0 0 0 0 .9 5 4 0 .6 6 2 0 .5 8 9
0 .7 1 2 8 0 .6 2 5 9 0 .2 9 8 2 0 .6 7 9 6 0 .0 0 0 0 0 .0 0 3 1 0 .1 5 2 0 0 .2 1 9 1
VASA1 - 0 .4 4 9 - 0 .0 4 6 - 0 .4 6 7 -0 .3 6 7 0 .9 5 4 1 .0 0 0 0 .4 7 4 0 .4 4 5
0 .3 7 1 0 0 .9 3 1 5 0 .3 5 0 2 0 .4 7 3 9 0 .0 0 3 1 0 .0 0 0 0 0 .3 4 2 1 0 .3 7 6 7
TIME1 0 .3 0 0 - 0 .4 8 2 - 0 .6 3 2 - 0 .0 3 5 0 .6 6 2 0 .4 7 4 1 .0 0 0 0 .3 1 1
0 .5 6 3 2 0 .3 3 2 6 0 .1 7 7 8 0 .9 4 6 9 0 .1 5 2 0 0 .3 4 2 1 0 .0 0 0 0 .5 4 7 9
MONT 0 .4 6 0 -0 .7 7 1 - 0 .0 7 0 0 .4 0 7 0 .5 8 9 - 0 .4 4 5 0 .3 1 1 1 .0 0 0
0 .3 5 8 3 0 .0 7 2 8 0 .8 9 4 6 0 .4 2 2 7 0 .2 1 9 1 0 .3 7 6 7 0 .5 4 7 9 0 .0 0 0 0
BLUNT 0 .7 2 9 - 0 .7 2 9 0 .5 3 2 0 .9 1 2 - 0 .1 2 8 - 0 .2 4 7 0 .0 4 2 0 .4 9 6
0 .1 0 0 4 0 .1 0 0 4 0 .2 7 7 1 0 .0 1 1 3 0 .8 0 8 7 0 .6 3 6 9 0 .9 3 6 9 0 .3 1 6 9
RELAX2 0 .1 3 9 0 .2 0 0 0 .4 8 8 0 .3 4 4 - 0 .6 8 0 - 0 .6 4 8 - 0 .1 8 4 - 0 .6 6 4
0 .7 9 1 6 0 .7 0 3 5 0 .3 2 6 3 0 .5 0 4 6 0 .1 3 6 9 0 .1 6 4 3 0 .7 2 7 2 0 .1 5 0 3
C0NFS2 0 .4 6 2 - 0 .3 0 7 0 .6 3 2 0 .8 6 2 0 .0 1 3 -0 .1 1 7 0 .2 0 0 0 .2 2 2
0 .3 5 5 8 0 .5 5 4 0 0 .1 7 7 8 0 .0 2 7 1 0 .9 7 9 9 0 .8 2 5 6 0 .7 0 4 0 0 .6 7 1 8
CQNFV2 0 .5 7 6 - 0 .3 8 9 0 .71B 0 .94B - 0 .0 6 5 - 0 .2 1 4 0 .0 3 8 0 .3 7 9
0 .2 3 1 9 0 .4 4 4 7 0 .1 0 8 1 0 .0 0 3 9 0 .9 0 2 6 0 .6 8 3 1 0 .9 4 3 3 0 .4 5 8 9
STAI2 - 0 .2 2 5 0 .2 1 2 -0 .2 5 5 -0 .5 0 6 - 0 .1 6 7 - 0 .0 9 4 - 0 .5 8 4 0 .0 3 6
0 .6 6 8 3 0 .6 8 6 1 0 .6 2 5 3 0 .3 0 6 2 0 .7 5 1 5 0 .8 5 9 0 0 .3 3 0 1 0 .9 4 6 1
EXPECT 0 .2 9 4 0 .0 2 7 0 .0 2 8 0 .0 8 1 - 0 .6 7 2 - 0 .7 0 0 0 .0 3 6 - 0 .6 5 5
0 .5 7 1 2 0 .9 5 8 7 0 .9 5 7 4 0 .8 7 9 3 0 .1 4 3 4 0 .1 2 1 2 0 .9 4 6 1 0 .1 5 7 7
VAS12 - 0 .3 7 7 -0 .0 7 1 - 0 .5 8 2 - 0 .4 3 6 0 .9 5 3 0 .9 5 6 0 .4 9 5 0 .5 0 3
0 .4 6 1 4 0 .8 9 4 2 0 .2 2 5 9 0 .3 8 7 6 0 .0 0 3 2 0 .0 0 2 8 0 .3 1 8 5 0 .3 0 8 5
VASA2 - 0 .3 8 3 - 0 .0 6 8 - 0 .4 5 8 - 0 .3 3 3 0 .9 6 6 0 .9 7 6 0 .4 6 7 0 .5 2 8
0 .4 5 3 7 0 .8 9 8 6 0 .3 6 0 5 0 .5 1 9 2 0 .0 0 1 7 0 .0 0 0 8 0 .3 4 9 7 0 .2 8 1 0
TIME2 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0
I . 0000 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0
BLUNT RELAX2 C0NFS2 C0NFV2
RELAX1 0 .7 2 9 0 .1 3 9 0 .4 6 2 0 .5 7 6
0 .1 0 0 4 0 .7 9 1 6 0 .3 5 5 8 0 .2 3 1 9
STAU - 0 .7 2 9 0 .2 0 0 - 0 .3 0 7 -0 .3 8 9
0 .1 0 0 4 0 .7 0 3 5 0 .5 5 4 0 0 .4 4 4 7
C0NFS1 0 .5 3 2 0 .4 8 8 0 .6 3 2 0 .7 1 8
0 .2 7 7 1 0 .3 2 6 3 0 .1 7 7 8 0 .1 0 8 1
CONFV1 0 .9 1 2 0 .3 4 4 0 .8 6 2 0 .9 4 8
0 .0 1 1 3 0 .5 0 4 6 0 .0 2 7 1 0 .0 0 3 9
VASI1 - 0 .1 2 8 - 0 .6 8 0 0 .0 1 3 - 0 .0 6 5
0 .8 0 8 7 0 .1 3 6 9 0 .9 7 9 9 0 .9 0 2 6
VASA1 - 0 .2 4 7 - 0 .6 4 8 - 0 .1 1 7 - 0 .2 1 4
0 .6 3 6 9 0 .1 6 4 3 0 .8 2 5 6 0 .6 8 3 1
TIME1 0 .0 4 2 - 0 .1 8 4 0 .2 0 0 0 .0 3 8
0 .9 3 6 9 0 .7 9 7 2 0 .7 0 4 0 0 .9 4 3 3
MONT 0 .4 9 6 - 0 .6 6 4 0 .2 2 2 0 .3 7 9
0 .3 1 6 9 0 .1 5 0 3 0 .6 7 1 8 0 .4 5 8 9
BLUNT 1 .0 0 0 0 .3 0 8 0 .7 1 5 0 .7 7 2
0 .0 0 0 0 0 .5 5 2 2 0 .1 1 0 1 0 .0 7 2 0
RELAX2 0 .3 0 8 1 .0 0 0 0 .4 3 3 0 .2 8 2
0 .5 5 2 2 0 .0 0 0 0 0 .3 9 0 9 0 .5 8 8 5
C0NFS2 0 .7 1 5 0 .4 3 3 l.OOu 0 .9 4 6
O .i iO i 0 .3 9 0 9 0 .0 0 0 0 0 .0 0 4 3
CONFV2 0 .7 7 2 0 .2 8 2 0 .9 4 6 1 .0 0 0
0 .0 7 2 0 0 .5 8 8 5 0 .0 0 4 3 0 .0 0 0 0
STAI2 -0 .5 0 9 - 0 .5 7 0 -0 .8 0 7 -0 .5 8 1
0 .3 0 1 7 0 .2 3 7 4 0 .0 5 2 0 0 .2 2 6 9
EXPECT 0 .1 2 8 0 .8 3 9 0 .0 7 2 -0 .0 6 1
0 .8 0 8 4 0 .0 3 6 9 0 .8 9 2 4 0 .9 0 8 4
VAS12 - 0 .3 6 3 - 0 .8 1 3 -0 .2 4 1 -0 .2 7 9
0 .4 7 9 1 0 .0 4 9 0 0 .6 4 5 4 0 .5 9 2 0
VASA2 - 0 .2 7 4 - 0 .7 6 2 -0 .1 1 2 -0 .1 5 9
0 .5 9 9 1 0 .0 7 8 4 0 .8 3 2 4 0 .7 6 3 1
TINE2 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0
1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0
STAI2 EXPECT VASI2 VASA2 TIME2
- 0 .2 2 5 0 .2 9 4 - 0 .3 7 7 - 0 .3 8 3 0 .0 0 0
0 .6 6 8 3 0 .5 7 1 2 0 .4 6 1 4 0 .4 5 3 7 I . 0000
0 .2 1 2 0 .0 2 8 -0 .0 7 1 - 0 ,0 6 8 0 .0 0 0
0 .6 8 6 1 0 .9 5 8 7 0 .8 9 4 2 0 .8 9 8 6 1 .0 0 0 0
- 0 .2 5 5 0 .0 2 8 - 0 .5 8 2 - 0 .4 5 8 0 .0 0 0
0 .6 2 5 3 0 .9 5 7 4 0 .2 2 5 9 0 .3 6 0 5 1 .0 0 0 0
- 0 .5 0 6 0 .0 8 1 - 0 .4 3 6 - 0 .3 2 3 0 .0 0 0
0 .3 0 6 2 0 .8 7 9 3 0 .3 8 7 6 0 .5 1 9 2 1 .0 0 0 0
- 0 .1 6 7 - 0 .6 7 2 0 .9 5 3 0 .9 6 6 0 .0 0 0
0 .7 5 1 5 0 .1 4 3 2 0 .0 0 3 2 0 .0 0 1 7 1 .0 0 0 0
- 0 .0 9 4 - 0 .7 0 0 0 .9 5 6 0 .9 7 6 0 .0 0 0
0 .8 5 9 0 0 .1 2 1 2 0 .0 0 2 8 0 .0 0 0 8 1 .0 0 0 0
- 0 .4 8 4 0 .0 3 6 0 .4 9 4 0 .4 6 8 0 .0 0 0
0 .3 3 0 1 0 .9 4 6 1 0 .3 1 8 5 0 .3 4 9 7 1 .0 0 0 0
0 .0 3 6 - 0 .6 5 5 0 .5 0 3 0 .5 2 8 0 .0 0 0
0 .9 4 6 1 0 .1 5 7 7 0 .3 0 8 5 0 .2 8 1 0 1 .0 0 0 0
- 0 .5 0 9 0 .1 2 8 - 0 .3 6 3 -0 .2 7 4 0 .0 0 0
0 .3 0 1 7 0 .8 0 8 4 0 .4 7 9 1 0 .5 9 9 1 1 .0 0 0 0
- 0 .5 7 0 0 .8 3 9 - 0 .8 1 3 -0 .7 6 2 0 .0 0 0
0 .2 3 7 4 0 .0 3 6 9 0 .0 4 9 0 C.0784 1 .0 0 0 0
- 0 .8 0 7 0 .0 7 2 -0 .2 4 1 -0 .1 1 2 0 .0 0 0
0 .0 5 2 0 0 .8 9 2 4 0 .6 4 5 4 0 .8 3 2 4 1 .0 0 0 0
-0 .5 8 1 -0 .0 6 1 -0 .2 7 9 -0 .1 5 9 0 .0 0 0
0 .2 2 6 9 0 .9 0 8 4 0 .5 9 2 0 0 .7 6 3 1 1 .0 0 0 0
1 .0 0 0 - 0 .3 1 9 0 .1 0 8 0 .0 0 5 0 .0 0 0
0 .0 0 0 0 0 .5 3 7 6 0 .8 3 6 2 0 .9 9 2 4 1.UOO0
-0 .3 1 9 1 .0 0 0 -6 .7 6 2 -0 .7 9 7 0 .0 0 0
0 .5 3 7 6 0 .0 0 0 0 0 .0 7 7 9 0 .0 5 7 4 1 .0 0 0 0
0 .1 0 8 - 0 .7 6 2 1 .0 0 0 0 .9 8 7 0 .0 0 0
0 .8 3 8 2 0 .0 7 7 9 0 .0 0 0 0 0 .0 0 0 2 1 .0 0 0 0
0 .0 0 5 0 .7 8 7 0 .9 8 7 1 .0 0 0 0 .0 0 0
0 .9 9 2 4 0 .0 5 7 4 0 .0 0 0 2 0 .0 0 0 0 1 .0 0 0 0
0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0
1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0
125
Table 33
Correlation matrix for athletes in control group.
RELAX1 STAI1 C0NFS1 C0NFV1 VAS11 VASA1 TIME1 MONT
RELAX1 1 .0 0 0 -0 .9 0 1 0 .5 1 7 0 .6 4 4 - 0 .3 2 0 - 0 .4 3 6 0 .2 3 8 - 0 .2 6 7
0 .0 0 0 0 0 .0 1 4 1 0 .2 9 3 7 0 .1 6 7 7 0 .5 3 6 1 0 .3 8 6 8 0 .6 5 0 1 0 .6 0 9 3
STAU -0 .9 0 1 1 .0 0 0 - 0 .6 9 9 - 0 .7 4 0 0 .4 2 3 0 .7 0 7 - 0 .3 7 8 0 .5 9 0
0 .0 1 4 1 0 .0 0 0 0 0 .1 2 2 4 0 .0 9 2 4 0 .4 0 3 1 0 .1 1 5 9 0 .4 6 0 3 0 .2 1 7 4
CflNFSl 0 .5 1 6 9 - 0 .6 9 9 1 .0 0 0 0 .9 7 4 - 0 .7 5 3 - 0 .9 6 3 0 .9 0 1 - 0 .5 7 2
0 .2 9 3 7 0 .1 2 2 4 0 .0 0 0 0 0 .0 0 1 0 0 .0 8 4 1 0 .0 0 2 0 0 .0 1 4 1 0 .2 3 5 8
C0NFV1 0 .6 4 4 - 0 .7 4 0 0 .9 7 4 1 .0 0 0 - 0 .6 8 8 - 0 .9 0 4 0 .8 5 7 - 0 .5 1 0
0 .1 6 7 7 0 .0 9 2 4 0 .0 0 1 0 0 .0 0 0 0 0 .1 3 0 6 0 .0 1 3 3 0 .0 2 9 0 0 .3 0 1 1
VASI1 - 0 .3 2 0 0 .4 2 3 - 0 .7 5 3 - 0 .6 8 8 1 .0 0 0 0 .6 2 9 -0 .7 6 1 0 .0 0 5
0 .5 3 6 1 0 .4 0 3 1 0 .0 8 4 1 0 .1 3 0 6 0 .0 0 0 0 0 .1 8 1 1 0 .0 7 9 0 0 .9 9 3 0
VASA1 - 0 .4 3 6 0 .7 0 7 - 0 .9 6 3 - 0 .9 0 4 0 .6 2 9 1 .0 0 0 - 0 .8 2 5 0 .7 5 6
0 .3 8 6 8 0 .1 1 5 9 0 .0 0 2 0 0 .0 1 3 3 0 .1 8 1 1 0 .0 0 0 0 0 .0 4 3 1 0 .0 8 1 9
TIHE1 0 .2 3 8 - 0 .3 7 8 0 .9 0 1 0 .8 5 7 -0 .7 6 1 - 0 .8 2 5 1 .0 0 0 - 0 .3 6 2
0 .6 5 0 1 0 .4 6 0 3 0 .0 1 4 1 0 .0 2 9 0 0 .0 7 9 0 0 .0 4 3 1 0 .0 0 0 0 .4 8 0 2
MONT -0 .2 6 7 0 .5 9 0 - 0 .5 7 2 - 0 .5 1 0 0 .0 0 4 0 .7 5 6 - 0 .3 6 2 1 .0 0 0
0 .6 0 9 3 0 .2 1 7 4 0 .2 3 5 8 0 .3 0 1 1 0 .9 9 3 0 0 .0 8 1 9 0 .4 8 0 2 0 .0 0 0 0
BLUNT - 0 .9 0 1 0 .6 5 6 - 0 .3 8 7 -0 .5 5 1 0 .3 5 3 0 .2 1 1 - 0 .2 5 9 -0 .1 0 1
0 .0 1 4 1 0 .1 5 7 2 0 .4 4 8 2 0 .2 5 7 5 0 .4 9 1 9 0 .6 8 8 6 0 .6 1 9 8 0 .8 4 8 5
RELAX2 0 .4 4 9 - 0 .7 8 2 0 .7 0 5 0 .6 0 8 - 0 .4 2 7 - 0 .8 3 0 0 .4 8 6 - 0 .8 2 9
0 .3 7 0 9 0 .0 6 5 9 0 .1 1 7 7 0 .1 9 9 9 0 .3 9 8 7 0 .0 4 0 7 0 .3 2 7 8 0 .0 4 1 5
C0NFS2 0 .5 6 7 - 0 .4 8 7 0 .7 8 4 0 .8 8 0 - 0 .5 7 8 - 0 .6 2 8 0 .7 3 4 -0 .1 5 B
0 .2 4 0 3 0 .3 2 6 8 0 .0 6 5 0 0 .0 2 0 0 .2 2 9 8 0 .1 8 1 9 0 .0 9 6 6 0 .7 6 4 9
CQNFV2 0 .6 4 8 - 0 .6 4 9 0 .8 8 8 0 .9 5 9 -0 .6 3 3 - 0 .7 7 3 0 .7 7 3 - 0 .3 3 8
0 .1 6 3 9 0 .1 6 2 8 0 .01B 0 0 .0 0 2 5 0 .1 7 7 5 0 .0 7 1 2 0 .0 7 1 3 0 .5 1 7 7
STAU - 0 .6 4 8 0 .B 92 - 0 .5 4 1 -0 .5 0 1 0 .2 2 3 0 .6 6 6 -0 .1 8 7 0 .7 7 8
0 .1 6 3 7 0 .0 1 6 8 0 .2 6 7 8 0 .3 0 2 4 0 .6 7 1 0 0 .1 4 8 2 0 .7 2 2 1 0 .0 6 8 2
EXPECT 0 .7 8 7 - 0 .5 8 8 - 0 .1 0 7 0 .0 4 6 0 .2 1 5 0 .1 3 9 - 0 .3 9 9 -0 .0 1 1
0 .0 6 3 2 0 .2 1 9 9 0 .8 3 9 3 0 .9 3 1 0 0 .6 8 2 3 0 .7 9 2 3 0 .4 3 3 2 0 .7 8 3 7
VASU - 0 .7 9 7 0 .6 8 1 - 0 .3 6 5 - 0 .4 5 2 0 .5 2 7 0 .2 3 6 - 0 .0 8 8 - 0 .1 2 4
0 .0 5 7 5 0 .1 3 6 0 0 .4 7 6 9 0 .3 6 7 6 0 .2 8 2 7 0 .6 5 2 9 0 .8 6 8 5 0 .8 1 5 1
VASA2 - 0 .8 9 5 0 .9 4 3 - 0 .8 1 3 - 0 .8 8 2 0 .5 2 4 0 .7 6 6 -0 .5 3 1 0 .5 1 1
0 .0 1 6 0 0 .0 0 4 8 0 .0 4 8 9 0 .0 2 0 0 0 .2 8 6 4 0 .0 7 5 4 0 .2 7 8 7 0 .3 0 0 5
TINE2 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0
1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 I . 0000
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BLUNT RELAX2 C0NFS2 CQNFV2
RELAX 1 -0 .9 0 1 0 .4 4 9 0 .5 6 7 0 .6 4 8
0 .0 1 4 1 0 .3 7 0 9 0 .2 4 0 3 0 .1 6 3 9
5TAI1 0 .6 5 6 - 0 .7 8 2 - 0 .4 8 7 - 0 .6 4 9
0 .1 5 7 2 0 .0 6 5 9 0 .3 2 6 8 0 .1 6 2 8
C0NFS1 - 0 .3 8 7 0 .7 0 5 0 .7 8 4 0 .8 8 8
0 .44B 2 0 .1 1 7 7 0 .0 6 5 0 0 .0 1 8 0
CONFV1 -0 .5 5 1 0 .6 0 8 0 .8 8 0 0 .9 5 9
0 .2 5 7 5 0 .1 9 9 9 0 .0 2 0 5 0 .0 0 2 5
VASI1 0 .3 5 3 - 0 .4 2 7 - 0 .5 7 8 - 0 .6 3 3
0 .4 9 1 9 0 .3 9 8 7 0 .2 2 9 8 0 .1 7 7 5
VASA1 0 .2 1 1 - 0 .8 3 0 - 0 .6 2 8 - 0 .7 7 3
0.6BB 6 0 .0 4 0 7 0 .1 8 1 9 0 .0 7 0 2
TIME1 -0 .2 5 9 0 .4 8 6 0 .7 3 4 0 .7 7 3
0 .6 1 9 8 0 .3 2 7 8 0 .0 9 6 6 0 .0 7 1 3
HON! -0 .1 0 1 -0 .8 2 9 - 0 .1 5 8 - 0 .3 3 8
0 .8 4 9 5 0 .0 4 1 5 0 .7 6 4 9 0 .5 1 1 7
BLUNT 1 .0 0 0 - 0 .1 1 5 - 0 .6 2 9 -0 .6 1 B
0 .0 0 0 0 0 .8 2 8 0 0 .1 8 1 2 0 .1 9 0 9
RELAX2 - 0 .1 1 5 1 .0 0 0 0 .1 6 6 0 .3 6 5
O.BzBO 0 .0 0 0 0 0 .7 5 2 7 0 .4 5 0 9
CGNFSZ -0 .6 2 9 0 .1 6 6 1 .0 0 0 0 .9 7 3
0 .1 8 1 2 0 .7 5 2 7 0 .0 0 0 0 0 .0 0 1 1
C0NFV2 - 0 .6 1 8 0 .3 8 5 0 .9 7 3 1 .0 0 0
0 .1 9 0 9 0 .4 5 0 9 0 .0 0 1 1 0 .0 0 0 0
STAI2 0 .2 7 2 - 0 .9 0 5 - 0 .1 3 2 -0 .3 4 9
0 .6 0 1 7 0 .0 1 3 0 0 .8 0 3 0 0 .4 9 8 0
EXPECT - 0 .7 0 7 0 .0 9 9 0 .0 4 9 0 .0 9 3
0 .1 1 6 2 0 .8 5 2 2 0 .9 2 5 2 0 .8 6 0 3
VAS12 0 .7 5 6 - 0 .2 1 8 - 0 .4 7 8 - 0 .5 2 6
0 .0 8 1 9 0 .6 7 8 6 0 .3 3 8 1 0 .2 8 3 2
VASA2 0 .7 1 7 - 0 .6 4 7 - 0 .7 4 4 - 0 .8 5 8
0 .1 0 8 9 0 .1 6 4 6 0 .0 9 0 1 0 .0 2 8 8
TII1E2 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0
1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0
STAI2 EXPECT VA5I2 VASA2 TIHE2
- 0 .6 4 8 0 .7 8 7 - 0 .7 9 7 - 0 .8 4 5 0 .0 0 0
0 .1 6 3 7 0 .0 6 3 2 0 .0 5 7 5 0 .0 1 6 0 1 .0 0 0 0
0 .8 9 2 - 0 .5 8 8 0 .6 8 1 0 .9 4 3 0 .0 0 0
0 .0 1 6 8 0 .2 1 9 9 0 .1 3 6 0 0 .0 0 4 8 1 .0 0 0 0
-0 .5 4 1 - 0 .1 0 7 - 0 .3 6 5 0 .0 4 9 0 .0 0 0
0 .2 6 7 8 0 .8 3 9 3 0 .4 7 6 9 0 .0 4 8 9 1 .0 0 0 0
- 0 .5 0 9 0 .0 4 6 - 0 .4 5 2 - 0 .8 8 2 0 .0 0 0
0 .3 0 2 4 0 .9 3 1 0 0 .3 6 7 6 0 .0 2 0 0 1 .0 0 0 0
0 .2 2 3 0 .2 1 5 0 .5 2 7 0 .5 2 4 0 .0 0 0
0 .6 7 1 0 0 .6 8 2 3 0 .2 8 2 7 0 .2 8 6 4 1 .0 0 0 0
0 .6 6 6 0 .1 3 9 0 .2 3 6 0 .7 6 6 0 .0 0 0
0 .1 4 8 2 0 .7 9 2 3 0 .6 5 2 9 0 .0 7 5 4 1 .0 0 0 0
-0 .1 B 7 -0 .3 9 9 - 0 .0 8 8 -0 .5 3 1 0 .0 0 0
0 .7 2 2 1 0 .4 3 3 2 0 .8 6 6 5 0 .27B 7 1 .0 0 0 0
0 .7 7 8 -0 .0 1 1 - 0 .1 2 4 0 .5 1 1 0 .0 0 0
0 .0 6 8 2 0 .9 8 3 7 0 .8 1 5 1 0 . 3 0 0 5 1 .0 0 0 0
0 .2 7 2 - 0 . 7 0 7 0 . 7 5 6 0 .7 1 7 0 .0 0 0
0 .6 0 1 7 0 . 1 1 6 2 0 . 0 8 1 9 0 . 1 0 6 9 1 .0 0 0 0
- 0 . 9 0 5 0 . 0 9 9 - 0 . 2 1 8 - 0 .6 4 7 0 .0 0 0
0 .0 1 3 0 0 .8 5 2 2 0 .67B 6 0 .1 6 4 6 1 .0 0 0 0
- 0 .1 3 2 0 .0 4 9 - 0 .4 7 8 - 0 .7 4 4 0 .0 0 0
0 .8 0 3 0 0 .9 2 5 2 0 .3 3 8 1 0 .0 9 0 1 1 .0 0 0 0
- 0 .3 4 9 0 .0 9 3 - 0 .5 2 6 - 0 .8 5 8 0 .0 0 0
0 .4 9 8 0 0 .8 6 0 3 0 .2 8 3 2 0 .0 2 8 8 1 .0 0 0 0
1 .0 0 0 - 0 .4 5 9 0 .4 3 4 0 .7 3 7 0 .0 0 0
0 .0 0 0 0 0 .3 6 0 3 0 .3 9 0 2 0 .0 9 4 8 1 .0 0 0 0
- 0 .4 5 9 1 .0 0 0 - 0 .6 3 4 - 0 .4 7 4 0 .0 0 0
0 .3 6 0 3 0 .0 0 0 0 0 .1 7 3 8 0 .3 4 1 9 1 .0 0 0 0
0 .4 3 4 - 0 .6 3 7 1 .0 0 0 0 .7 1 7 0 .0 0 0
0 .3 9 0 2 0 .1 7 3 8 0 .0 0 0 0 0 .1 0 8 6 1 .0 0 0 0
0 .7 3 7 - 0 .4 7 4 0 .7 1 7 1 .0 0 0 0 .0 0 0
0 .0 9 4 8 0 .3 4 1 9 0 .1 0 8 6 0 .0 0 0 0 1 .0 0 0 0
0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0
1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0
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Table 34
Correlation matrix for non-athletes in humor treatment.
RELAX1 STAU CONFSI C0NFV1 VASU VASA1 TIHE1 E10NT
RELAX 1 1 .0 0 0 - 0 .8 3 0 0 .6 2 1 0 .7 3 5 - 0 .1 6 2 - 0 .1 8 5 0 .0 0 0 0 .3 8 5
0 .0 0 0 0 0 .0 4 0 9 0 .1 8 8 2 0 .0 9 6 1 0 .7 5 9 3 0 .7 2 5 0 1 .0 0 0 4 0 .4 5 1 3
STAU - 0 .0 3 0 1 .0 0 0 - 0 .6 4 6 - 0 .7 7 3 0 .4 7 4 0 .5 1 7 0 .0 0 0 0 .1 0 2
0 .0 4 0 9 0 .0 0 0 0 0 .1 6 5 7 0 .0 7 1 6 0 .3 4 2 5 0 .2 9 3 1 1 .0 0 0 0 0 .0 4 7 6
CONFSi 0 .6 2 1 - 0 .6 4 6 1 .0 0 0 0 .7 0 5 - 0 .0 1 7 0 .0 4 5 0 .0 0 0 - 0 .2 9 4
0 .1 6 8 2 0 .1 6 5 7 0 .0 0 0 0 0 .1 1 7 4 0 .9 7 4 7 0 .9 3 2 7 1 .0 0 0 0 0 .5 7 1 0
C0NFV1 0 .7 3 5 - 0 .7 7 3 0 .7 0 5 1 .0 0 0 - 0 .6 2 2 - 0 .5 6 6 0 .0 0 0 0 .0 7 5
0 .0 9 1 6 0 .0 7 1 6 0 .1 1 7 4 0 .0 0 0 0 0 .1 8 7 6 0 .2 4 2 0 1 .0 0 0 0 0 .8 8 8 2
VASU - 0 .1 6 2 0 .4 7 4 - 0 .0 1 7 - 0 .6 2 2 1 .0 0 0 0 .9 8 3 0 .0 0 0 0 .0 9 8
0 .7 5 9 3 0 .3 4 2 5 0 .9 7 4 7 0 .1 8 7 6 0 .0 0 0 0 0 .0 0 0 4 1 .0 0 0 0 0 .8 5 3 0
VASA1 - 0 .1 8 5 0 .5 1 7 0 .0 4 5 - 0 .5 6 6 0 .9 8 3 1 .0 0 0 0 .0 0 0 0 .0 8 6
0 .7 2 5 0 0 .2 9 3 1 0 .9 3 2 7 0 .2 4 2 0 0 .0 0 0 4 0 .0 0 0 0 1 .0 0 0 0 0 .8 7 1 8
TIHE1 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0
1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0
MONT 0 .3 8 5 0 .1 0 2 - 0 .2 9 4 0 .0 7 5 0 .0 9 8 0 .0 8 6 0 .0 0 0 1 .0 0 0
0 .4 5 1 3 0 .8 4 7 6 0 .5 7 1 0 0 .8 8 8 2 0 .8 5 3 0 0 .8 7 1 8 1 .0 0 0 0 0 .0 0 0 0
BLUNT - 0 .6 6 2 0 .4 0 4 - 0 .4 0 0 - 0 .4 4 1 - 0 .1 2 7 -0 .07% 0 .0 0 0 - 0 .4 6 3
0 .1 5 1 6 0 .4 2 7 2 0 .4 3 2 0 0 .3 8 1 5 0 .8 0 9 8 0 .8 8 9 6 1 .0 0 0 0 0 .3 5 5 4
RELAX2 0 .4 9 9 - 0 .4 2 6 - 0 .2 8 3 0 .3 4 3 - 0 .5 2 3 - 0 .6 1 3 0 .0 0 0 0 .6 3 1
0 .3 1 4 0 0 .3 9 9 9 0 .5 8 6 7 0 .5 0 5 8 0 .2 8 6 7 0 .1 9 5 8 1 .0 0 0 0 0 .1 7 9 0
CQNFS2 - 0 .1 8 5 0 .0 8 5 - 0 .7 9 0 - 0 .2 3 5 - 0 .4 2 5 - 0 .5 3 5 0 .0 0 0 0 .3 3 3
0 .7 2 6 1 0 .8 7 2 6 0 .0 6 1 2 0 .6 5 3 7 0 .4 0 0 3 0 .2 7 4 2 1 .0 0 0 0 0 .5 1 9 5
C0NFV2 0 .4 1 8 - 0 .1 4 4 - 0 .4 2 7 0 .1 2 1 - 0 .2 2 5 - 0 .2 9 8 0 .0 0 0 0 .8 6 8
0 .4 0 9 5 0 .7 8 5 0 0 .3 9 8 9 0 .0 1 8 9 0 .6 6 7 8 0 .5 6 6 1 1 .0 0 0 0 0 .0 2 4 8
STAU - 0 .5 6 4 0 .3 9 0 0 .2 2 7 - 0 .2 4 2 0 .2 4 4 0 .3 5 8 0 .0 0 0 - 0 .7 0 6
0 .2 4 3 3 0 .4 4 4 1 0 .6 6 5 0 0 .6 4 4 4 0 .6 4 1 3 0 .4 8 6 1 1 .0 0 0 0 0 .1 1 7 2
EXPECT 0 .2 4 9 - 0 .3 5 2 -0 .3 9 1 - 0 .0 9 9 - 0 .2 7 7 - 0 .3 0 7 0 .0 0 0 0 .2 0 1
0 .6 3 3 9 0 .4 9 3 3 0 .4 4 3 7 0 .8 5 1 4 0 .5 9 5 2 0 .4 4 8 4 1 .0 0 0 0 0 .7 0 2 0
VAS12 - 0 .3 5 4 0 .6 0 7 - 0 .2 1 4 - 0 .7 6 7 0 .9 6 6 0 .9 3 0 0 .0 0 0 0 .0 5 6
0 .4 9 1 3 0 .2 0 1 1 0 .6 6 4 0 0 .0 7 4 8 0 .0 0 1 7 0 .0 0 7 2 1 .0 0 0 0 0 .9 1 6 0
VASA2 - 0 .3 1 9 0 .5 9 4 0 .0 4 3 - 0 .5 8 6 0 .9 5 1 0 .9 8 1 0 .0 0 0 -0 .0 3 7
0 .5 3 6 8 0 .2 1 3 8 0 .9 3 5 8 0 .2 2 1 4 0 .0 0 3 5 0 .0 0 0 5 1 .0 0 0 0 0 .9 4 4 0
TIME2 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0
1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0
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BLUNT RELAX2 C0NFS2 C0NFV2
RELAX1 - 0 .6 6 2 0 .4 9 9 - 0 .1 8 5 0 .4 1 8
0 .1 5 1 6 0 .3 1 4 0 0 .7 2 6 1 0 .4 0 9 5
STAU 0 .4 0 4 - 0 .4 2 6 0 .0 0 5 - 0 .1 4 4
0 .4 2 7 2 0 .3 9 9 9 0 .8 7 2 6 0 .7 8 5 0
CONFSI - 0 .4 0 0 - 0 .2 8 3 - 0 .7 9 0 - 0 .4 2 7
0 .4 3 2 0 0 .5 8 6 7 0 .0 6 1 2 0 .39B 9
CQNFV1 -0 .4 4 1 0 .3 4 3 - 0 .2 3 5 0 .1 2 1
0 .3 8 1 5 0 .5 0 5 8 0 .6 5 3 7 0 .8 1 8 9
VASU - 0 .1 2 7 - 0 .5 2 3 - 0 .4 2 5 - 0 .2 2 5
0 .B 098 0 .2 8 6 7 0 .4 0 0 3 0 .6 6 7 8
VASA1 - 0 .0 7 4 - 0 .6 1 3 - 0 .5 3 5 - 0 .2 9 8
0 .B 896 0 .195B 0 .2 7 4 2 0 .5 6 6 1
T lflE l 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0
1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0
MONT - 0 .4 6 3 0 .6 3 1 0 .3 3 3 0 .8 6 8
0 .3 5 5 4 0 .1 7 9 0 0 .5 1 9 5 0 .0 2 4 8
BLUNT 1 .0 0 0 - 0 .3 9 5 0 .0 7 9 - 0 .3 7 7
0 .0 0 0 0 0 .4 3 7 7 0 .8 0 1 7 0 .4 6 0 6
RELAX2 - 0 .3 9 5 1 .0 0 0 0 .7 4 3 0 .9 1 5
0 .4 3 7 7 0 .0 0 0 0 0 .0 9 0 6 0 .0 1 0 6
CONFS2 0 .0 7 9 0 .7 4 3 1 .0 0 0 0 .6 8 3
0 .8 0 1 7 0 .0 9 0 6 0 .0 0 0 0 0 .1 3 4 4
CONFV2 - 0 .3 7 7 0 .9 1 5 0 .6 8 3 1 .0 0 0
0 .4 6 0 6 0 .0 1 0 6 0 .1 3 4 4 0 .0 0 0 0
STAU 0 .6 1 2 - 0 .9 4 2 - 0 .6 4 5 - 0 .9 1 5
0 .1 9 6 7 0 .0 0 5 0 0 .1 6 6 6 0 .0 1 0 6
EXPECT 0 .2 1 5 0 .6 3 4 0 .6 3 3 0 .5 7 5
0 .6 8 2 6 0 .1 7 6 4 0 .1 7 7 1 0 .2 3 2 9
VAS12 - 0 .0 6 3 - 0 .4 9 8 -0 .2 4 7 - 0 .2 1 4
0 .9 0 6 0 0 .3 1 4 3 0 .6 3 6 9 0 .6 8 3 3
VASA2 - 0 .0 1 5 - 0 .7 2 0 - 0 .5 6 4 - 0 .4 3 0
0 .9 7 7 6 0 .1 0 6 2 0 .2 4 3 3 0 .3 9 4 3
TIME2 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0
1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0
STAI2 EXPECT VASI2 VASA2 TIME2
- 0 .5 6 4 0 .2 4 9 - 0 .3 5 4 - 0 .3 1 9 0 .0 0 0
0 .2 4 3 3 0 .6 3 3 9 0 .4 9 1 3 0 .5 3 6 8 1 .0 0 0 0
0 .3 9 0 - 0 .3 5 2 0 .6 0 7 0 .5 9 4 0 .0 0 0
0 .4 4 4 1 0 .4 9 3 3 0 .2 0 1 1 0 .2 1 3 8 1 .0 0 0 0
0 .2 2 7 - 0 .3 9 1 - 0 .2 1 4 0 .0 4 3 0 .0 0 0
0 .6 6 5 8 0 .4 4 3 7 0 .6 8 4 0 0 .9 3 5 8 1 .0 0 0 0
- 0 .2 4 2 - 0 .0 9 9 - 0 .7 6 7 - 0 .5 8 6 0 .0 0 0
0 .6 4 4 4 0 .8 5 1 4 0 .0 7 4 8 0 .2 2 1 4 1 .0 0 0 0
0 .2 4 4 - 0 .2 7 7 0 .9 6 6 0 .9 5 1 0 .0 0 0
0 .6 4 1 3 0 .5 9 5 2 0 .0 0 1 7 0 .0 0 3 5 1 .0 0 0 0
0 .3 5 8 - 0 .3 8 7 0 .9 3 0 0 .9 8 1 0 .0 0 0
0 .4 0 6 1 0 .4 4 8 4 0 .0 0 7 2 0 .0 0 0 5 1 .0 0 0 0
0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0
1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0
- 0 .7 0 6 0 .2 0 1 0 .0 5 6 -0 .0 3 7 0 .0 0 0
0 .1 1 7 2 0 .7 0 2 0 0 .9 1 6 0 0 .9 4 4 0 1 .0 0 0 0
0 .6 1 2 0 .2 1 5 - 0 .0 6 3 -0 .0 1 5 0 .0 0 0
0 .1 9 6 7 0 .6 8 2 6 0 .9 0 6 0 0 .9 7 7 6 1 .0 0 0 0
- 0 .9 4 2 0 .6 3 4 - 0 .4 9 8 - 0 .7 2 0 0 .0 0 0
0 .0 0 5 0 0 .1 7 6 4 0 .3 1 4 3 0 .1 0 6 2 1 .0 0 0 0
- 0 .6 4 5 0 .6 3 3 - 0 .2 4 7 - 0 .5 6 4 0 .0 0 0
0 .1 6 6 6 0 .1 7 7 1 0 .6 3 6 9 0 .2 4 3 3 1 .0 0 0 0
- 0 .9 1 5 0 .5 7 5 - 0 .2 1 4 -0 .4 3 0 0 .0 0 0
0 .0 1 0 6 0 .2 3 2 9 0 .6B 33 0 .3 9 4 3 1 .0 0 0 0
1 .0 0 0 - 0 .5 4 4 0 .2 2 9 0 .4 8 2 0 .0 0 0
0 .0 0 0 0 0 .2 6 3 8 0 .6 6 2 0 0 .3 3 2 0 1 .0 0 0 0
- 0 .5 4 4 1 .0 0 0 - 0 .2 6 4 -0 .5 1 6 0 .0 0 0
0 .2 6 3 8 0 .0 0 0 0 0 .6 1 3 2 0 .2 9 4 6 1 .0 0 0 0
0 .2 2 9 - 0 .2 6 4 1 .0 0 0 0 .9 2 4 0 .0 0 0
0 .6 6 2 0 0 .6 1 3 2 0 .0 0 0 0 0 .0 0 0 4 1 .0 0 0 0
0 .4 8 2 - 0 .5 1 6 0 .9 2 4 1 .0 0 0 0 .0 0 0
0 .3 3 2 8 0 .2 9 4 6 0 .0 0 8 4 0 .0 0 0 0 1 .0 0 0 0
0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0 0 .0 0 0
1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0 1 .0 0 0 0
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Table 35
Correlation matrix for non-athletes in relaxation group.
RELAX1 STAI1 CONFSI C0NFV1 VASI1 VASA1 TIMEI MONT
RELAX1 1 .0 0 0 - 0 .0 9 4 0 .1 3 4 - 0 .0 3 9 0 .4 1 2 0 .5 7 8 - 0 .2 9 6 0 .1 2 2
0 .0 0 0 0 0 .0 8 5 9 0 .8 0 0 2 0 .9 4 0 2 0 .4 1 8 3 0 .2 2 9 2 0 .5 6 8 5 0 .8 1 7 9
STAI1 - 0 .9 4 3 1 .0 0 0 - 0 .1 5 9 0 .5 1 6 0 .1 5 0 0 .4 2 3 - 0 .0 6 6 0 .2 8 9
0 .8 5 8 9 0 .0 0 0 0 0 .7 6 3 8 0 .2 9 4 7 0 .7 7 6 0 0 .4 0 2 6 0 .9 0 0 2 0 .5 7 8 4
CONFSI 0 .1 3 4 0 .1 5 9 1 .0 0 0 0 .8 9 1 - 0 .5 2 6 - 0 .2 4 4 0 .4 5 8 0 .4 3 3
0 .8 0 0 2 0 .7 6 3 8 0 .0 0 0 0 0 .0 1 7 1 0 .2 8 3 3 0 .6 4 1 2 0 .3 6 1 3 0 .3 9 0 4
C0NFV1 -0 .0 3 9 0 .5 1 6 0 .8 9 1 1 .0 0 0 -0 .3 9 4 - 0 .0 3 5 0 .3 0 1 0 .2 8 5
0 .9 4 0 2 0 .2 9 4 7 0 .0 1 7 1 0 .0 0 0 0 0 .4 3 9 4 0 .9 4 7 2 0 .5 6 1 6 0 .5 8 3 8
VASU 0 .4 1 1 0 .1 5 0 - 0 .5 2 6 -0 .3 9 4 1 .0 0 0 0 .8 7 4 - 0 .9 5 4 - 0 .4 9 9
0 .4 1 8 3 0 .7 7 6 0 0 .2 8 3 3 0 .4 3 9 4 0 .0 0 0 0 0 .0 2 2 9 0 .0 0 3 1 0 .3 1 3 7
VASA1 0 .5 7 8 0 .4 2 3 - 0 .2 4 4 - 0 .0 3 5 0 .8 7 4 1 .0 0 0 - 0 .8 2 9 -0 .3 6 1
0 .2 2 9 2 0 .4 0 2 6 0 .6 4 1 2 0 .9 4 7 2 0 .0 2 2 9 0 .0 0 0 0 0 .0 4 1 2 0 .4 8 1 3
TIMEi - 0 .2 9 6 - 0 .0 6 6 0 .4 5 8 0 .3 0 1 - 0 .9 5 4 - 0 .8 2 9 1 .0 0 0 0 .7 1 2
0 .5 6 8 5 0 .9 0 0 2 0 .3 6 1 3 0 .5 6 1 6 0 .0 0 3 1 0 .0 4 1 2 0 .0 0 0 0 0 .1 1 2 7
MONT 0 .1 2 2 0 .2 8 9 0 .4 3 3 0 .2 8 5 - 0 .4 9 9 -0 .3 6 1 0 .7 1 2 1 .0 0 0
0 .8 1 7 9 0 .5 7 8 4 0 .3 9 0 4 0 .5 8 3 8 0 .3 1 3 7 0 .4 8 1 3 0 .1 1 2 7 0 .0 0 0 0
BLUNT - 0 .3 5 0 - 0 .1 1 9 -0 .3 9 5 -0 .4 8 4 - 0 .4 2 9 - 0 .5 8 2 0 .5 9 9 0 .5 0 9
0 .4 9 6 1 0 .8 2 2 6 0 .4 3 8 6 0 .3 3 0 4 0 .3 9 4 9 0 .2 2 5 8 0 .2 0 8 8 0 .3 0 2 2
RELAX2 0 .5 5 5 -0 .5 3 1 0 .1 3 7 -0 .1 7 6 - 0 .3 7 2 - 0 .2 4 7 0 .4 4 5 0 .3 1 1
0 .2 5 3 1 0 .2 7 8 2 0 .795B 0 .7 3 8 0 0 .4 6 7 6 0 .6 3 7 0 0 .3 7 6 3 0 .5 4 7 5
C0NFS2 -0 .3 4 7 0 .0 6 5 0 .5 2 5 0 .4 8 4 - 0 .9 5 9 -0 .7 2 1 0 .9 3 4 0 .5 3 1
0 .4 9 9 9 0 .9 0 2 9 0 .2 8 5 0 0 .3 3 0 6 0 .0 0 2 4 0 .1 0 5 8 0 .0 0 6 3 0 .2 7 8 4
C0NFV2 -0 .4 4 9 0 .0 2 3 0 .5 0 3 0 .4 3 7 - 0 .9 8 2 - 0 .8 1 7 0 .9 6 2 0 .5 6 2
0 .3 7 2 1 0 .9 6 4 9 0 .3 0 9 3 0 .3 8 5 8 0 .0 0 0 5 0 .0 4 7 1 0 .0 0 2 2 0 .2 4 5 3
STAI2 -0 .4 1 3 0 .6 7 2 -0 .1 5 0 0 .2 4 4 0 .4 6 1 0 .4 5 9 - 0 .5 3 6 - 0 .3 8 2
0 .4 1 5 4 0 .1 4 3 3 0 .7 7 6 6 0 .6 4 0 8 0 .3 5 7 3 0 .3 5 9 8 0 .2 7 2 9 0 .4 5 4 3
EXPECT - 0 .5 3 8 0 .5 4 8 0 .4 2 2 0 .5 4 1 - 0 .6 9 0 - 0 .5 1 8 0 .7 4 6 0 .6 7 7
0 .2 7 1 0 0 .2 5 9 9 0 .4 0 3 5 0 .2 6 7 9 0 .1 2 9 0 0 .2 9 1 9 0 .0 8 8 7 0 .1 3 9 9
VAS12 0 .2 7 5 - 0 .1 4 5 -0 .4 9 1 -0 .4 0 9 0 .9 0 9 0 .7 1 2 - 0 .9 7 6 - 0 .7 6 9
0 .5 9 7 7 0 .7 8 4 3 0 .3 2 2 4 0 .4 1 1 9 0 .0 1 1 8 0 .1 1 2 5 1 .0 0 0 8 0 .0 7 3 6
VASA2 0 .2 8 5 0 .0 5 4 -0 .5 0 4 -0 .3 3 1 0 .9 4 0 0 .8 3 0 - 0 .9 9 4 - 0 .7 5 4
0 .5 8 4 5 0 .9 1 9 2 0 .3 0 7 6 0 .5 2 1 5 0 .0 0 5 2 0 .0 4 0 8 0 .0 0 0 1 0 .0 8 3 0
TIHE2 -0 .2 7 8 - 0 .0 8 5 0 .4 5 6 0 .2 9 0 - 0 .9 5 2 - 0 .8 2 9 0 .9 9 9 0 .7 1 2
0 .5 9 3 7 0 .8 7 2 1 0 .3 6 3 6 0 .5 7 7 0 0 .0 0 3 4 0 .0 4 1 4 0 .0 0 0 1 0 .1 1 2 7
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BLUNT RELAX2 C0NFS2 C0NFV2
RELAX 1 - 0 .3 5 0 0 .5 5 5 - 0 .3 4 7 - 0 .4 4 9
0 .4 9 6 1 0 .2 5 3 1 0 .4 9 9 9 0 .3 7 2 1
STAIL - 0 .1 1 9 - 0 .5 3 1 0 .0 6 5 0 .0 2 3
0 .8 2 2 6 0 .2 7 8 2 0 .9 0 2 9 0 .9 6 4 9
CONFSI - 0 .3 9 5 0 .1 3 7 0 .5 2 5 0 .5 0 3
0 .4 3 8 6 0 .7 9 5 8 0 .2 8 5 0 0 .3 0 9 3
CQNFV1 - 0 .4 8 4 - 0 .1 7 6 0 .4 8 4 0 .4 3 7
0 .3 3 0 4 0 .7 3 8 0 0 .3 3 0 6 0 .3 8 5 8
VASIi - 0 .4 2 9 - 0 .3 7 2 - 0 .9 5 9 -0 .9 8 2
0 .3 9 4 9 0 .4 6 7 6 0 .0 0 2 4 0 .0 0 0 5
VASA1 - 0 .5 8 2 - 0 .2 4 7 -0 .7 2 1 -0 .8 1 7
0 .2 2 5 8 0 .6 3 7 0 0 .1 0 5 8 0 .0 4 7 1
TINE1 0 .5 9 9 0 .4 4 5 0 .9 3 4 0 .9 6 2
0 .2 0 8 8 0 .3 7 6 3 0 .0 0 6 3 0 .0 0 2 2
NONT 0 .5 0 9 0 .3 1 2 0 .5 3 1 0 .5 6 2
0 .3 0 2 2 0 .5 4 7 5 0 .2 7 8 4 0 .2 4 5 3
BLUNT 1 .0 0 0 0 .2 7 6 0 .4 0 3 0 .4 7 3
0 .0 0 0 0 0 .5 9 6 6 0 .4 2 8 3 0 .3 4 3 2
RELAX2 0 .2 7 6 1 .0 0 0 0 .3 6 5 0 .2 9 2
0 .5 9 6 6 0 .0 0 0 0 0 .4 7 6 6 0 .5 7 4 3
C0NFS2 0 .4 0 3 0 .3 6 5 1 .0 0 0 0 .9 8 3
0 .4 2 8 3 0 .4 7 6 6 0 .0 0 0 0 0 .0 0 0 4
C0NFV2 0 .4 7 3 0 .2 9 2 0 .9 8 3 1 .0 0 0
0 .3 4 3 2 0 .5 7 4 3 0 .0 0 0 4 0 .0 0 0 0
STAI2 - 0 .3 9 0 - 0 .9 4 8 - 0 .3 7 4 - 0 .3 5 6
0 .4 4 4 1 0 .0 0 4 0 0 .4 6 5 6 0 .4 8 7 8
EXPECT 0 .4 3 4 - 0 .1 8 3 0 .7 6 1 0 .8 0 1
0 .3 9 0 1 0 .7 2 7 8 0 .0 7 8 8 0 .0 5 5 5
VAS12 -0 .5 6 1 - 0 .3 6 5 - 0 .9 4 4 -0 .9 5 4
0 .246B 0 .4 7 7 0 0 .0 0 4 6 0 .0 0 3 1
VASA2 - 0 .5 7 6 - 0 .4 0 9 -0 .9 0 7 - 0 .9 4 6
0 .2 3 1 2 0 .4 1 9 7 0 .0 1 2 5 0 .0 0 4 3
TIHE2 0 .6 0 0 0 .4 6 7 0 .9 3 0 0 .9 5 7
0 .2 0 7 9 0 .3 5 0 5 0 .0 0 7 1 0 .0 0 2 8
STAI2 EXPECT VASI2 VASA2 T1ME2
-0 .4 1 3 - 0 .5 3 8 0 .2 7 5 0 .2 8 5 - 0 .2 7 8
0 .4 1 4 5 0 .2 7 1 0 0 .5 9 7 7 0 .5 8 4 5 0 .5 9 3 7
0 .6 7 2 0 .5 4 8 - 0 .1 4 5 0 .0 5 4 - 0 .0 8 5
0 .1 4 3 3 0 .2 5 9 9 0 .7 8 4 3 0 .9 1 9 2 0 .8 7 2 1
-0 .1 5 0 0 .4 2 3 -0 .4 9 1 - 0 .5 0 4 0 .4 5 6
0 .7 7 6 6 0 .4 0 3 5 0 .3 2 2 4 0 .3 0 7 6 0 .3 6 3 6
0 .2 4 4 0 .5 4 1 - 0 .4 0 9 -0 .3 3 1 0 .2 9 0
0 .6 4 0 8 0 .2 6 7 9 0 .4 1 9 9 0 .5 2 1 5 0 .5 7 7 0
0 .4 6 1 - 0 .6 9 0 0 .9 0 9 0 .9 4 0 - 0 .9 5 2
0 .3 5 7 3 0 .1 2 9 0 0 .0 1 1 8 0 .0 0 5 2 0 .0 0 3 4
0 .4 5 9 - 0 .5 1 8 0 .7 1 2 0 .8 3 0 -0 .B 2 9
0 .3 5 9 8 0 .2 9 1 9 0 .1 1 2 5 0 .0 4 0 8 0 .0 4 1 4
-0 .5 3 6 0 .7 4 6 - 0 .9 7 6 -0 .9 9 4 0 .9 9 9
0 .2 7 2 9 0 .0 6 8 7 0 .0 0 0 8 0 .0 0 0 1 0 .0 0 0 1
- 0 .3 8 2 0 .6 7 7 - 0 .7 6 9 -0 .7 4 4 0 .7 1 2
0 .4 5 4 3 0 .1 3 9 9 0 .0 7 3 6 0 .0B 30 0 .1 1 2 7
- 0 .3 9 0 0 .4 3 4 -0 .5 6 1 - 0 .5 7 6 0 .6 0 0
0 .4 4 4 1 0 .3 9 0 1 0 .2 4 6 8 0 .2 3 1 2 0 .2 0 7 9
- 0 .9 4 8 - 0 .1 8 3 - 0 .3 6 5 - 0 .4 0 9 0 .4 6 7
0 .0 0 4 0 0 .7 2 7 8 0 .4 7 7 0 0 .4 1 9 7 0 .3 5 0 5
-0 .3 7 4 0 .7 6 1 - 0 .9 4 4 -0 .9 0 7 0 .9 3 0
0 .4 6 5 6 0 .0 7 8 8 0 .0 0 4 6 0 .0 1 2 5 0 .0 0 7 1
- 0 .3 5 6 0 .8 0 1 0 .9 5 4 - 0 .9 4 6 0 .9 5 7
0.4B7B 0 .0 5 5 5 0 .0 0 3 1 0 .0 0 4 3 0 .0 0 2 8
1 .0 0 0 0 .1 3 2 0 .4 1 2 0 .5 2 1 - 0 .5 5 7
0 .0 0 0 0 0 .8 0 3 3 0 .4 1 6 5 0 .2 8 8 9 0 .2 5 0 3
0 .1 3 2 1 .0 0 0 - 0 .8 4 0 - 0 .7 5 9 0 .7 2 9
0 .6 0 3 3 0 .0 0 0 0 0 .0 3 6 4 0 .4 0 8 0 0 0 .0 9 9 9
0 .4 1 2 - 0 .8 4 0 1 .0 0 0 0 .9 7 0 - 0 .9 7 3
0 .4 1 6 5 0 .0 3 6 4 0 .0 0 0 0 0 .0 0 1 3 0 .0 0 1 1
0 .5 2 1 - 0 .7 5 9 0 .9 7 0 1 .0 0 0 - 0 .9 9 3
0 .2 8 8 9 0 .0 8 0 0 0 .0 0 1 3 0 .0 0 0 0 0 .0 0 0 0
- 0 .5 5 7 0 .7 2 9 - 0 .9 7 3 - 0 .9 9 3 1 .0 0 0
0 .2 5 0 3 0 .0 9 9 9 0 .0 0 1 1 0 .0 0 0 1 0 .0 0 0 0
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Table 36
Correlation matrix for non-athletes in control
RELAX1 STAU CONFSI C0NFV1 VASU VASA1 TIMEI MONT
RELAX1 1 .0 0 0 - 0 .1 6 8 0 .4 5 8 - 0 .0 0 5 -0 .3 4 1 - 0 .2 6 4 0 .3 3 5 0 .4 0 8
0 .0 0 0 0 0 .7 5 0 3 0 .3 6 1 4 0 .9 9 1 4 0 .5 0 7 9 0 .6 1 3 5 0 .5 1 6 7 0 .4 2 1 8
STAU -0 .1 6 8 1 .0 0 0 - 0 .6 1 2 - 0 .1 8 2 0 .6 6 7 0 .7 0 3 - 0 .6 3 8 -0 .3 4 1
0 .7 5 0 3 0 .0 0 0 0 0 .1 9 6 9 0 .7 3 0 4 0 .1 4 8 0 0 .1 1 8 9 0 .1 7 2 5 0 .5 0 8 7
CONFSI 0 .4 5 B - 0 .6 1 2 1 .0 0 0 0 .7 3 9 0 .1 1 4 -0 .1 2 1 0 .2 4 5 0 .9 3 2
0 .3 6 1 4 0 .1 9 6 9 0 .0 0 0 0 0 .0 9 3 3 0 .8 2 9 2 0 .8 1 8 9 0 .6 3 9 2 0 .0 0 6 8
CQNFV1 - 0 .0 0 6 - 0 .1 8 2 0 .7 3 9 1 .0 0 0 0 .3 2 2 0 .3 0 6 - 0 .2 6 9 0 .7 7 1
0 .9 9 1 4 0 .7 3 0 4 0 .0 9 3 3 0 .0 0 0 0 0 .5 3 3 0 0 .5 5 4 8 0 .6 0 6 3 0 .0 7 2 4
VASII -0 .3 4 1 0 .6 6 7 - 0 .1 1 4 0 .3 2 2 1 .0 0 0 0 .9 9 5 - 0 .8 9 6 0 .0 8 8
0 .5 0 7 9 0 .1 4 8 0 0 .8 2 9 2 0 .5 3 3 0 0 .0 0 0 0 0 ,0 0 0 1 0 .0 1 5 8 0 .8 6 7 7
VASA1 - 0 .2 6 4 0 .7 0 3 -0 .1 2 1 0 .3 0 6 0 .9 9 5 1 .0 0 0 - 0 .9 0 9 0 .0 8 1
0 .6 1 3 5 0 .1 1 8 9 0 .8 1 8 9 0 .5 5 4 8 0 .0 0 0 1 0 .0 0 0 0 0 .0 1 1 9 0 .8 7 8 6
TIMEI 0 .3 3 5 - 0 .6 3 8 0 .2 4 5 - 0 .2 6 9 - 0 .8 9 6 - 0 .9 0 9 1 .0 0 0 0 .1 5 5
0 .5 1 6 7 0 .1 7 2 5 0 .6 3 9 2 0 .6 0 6 3 0 .0 1 5 8 0 .0 1 1 9 0 .0 0 0 0 .7 6 9 0
HQNT 0 .4 0 8 -0 .3 4 1 0 .9 3 2 0 .7 7 1 0 .0 B 8 0 .0 8 1 0 .1 5 5 1 .0 0 0
0 .421B 0 .5 0 8 7 0 .0 0 6 8 0 .0 7 2 4 0 .8 6 7 7 0 .8 7 8 6 0 .7 6 9 0 1 .0 0 0 0
BLUNT 0 .9 2 8 - 0 .2 9 3 0 .4 0 9 - 0 .0 4 1 - 0 .3 6 7 - 0 .2 8 9 0 .2 2 4 0 .2 4 4
0 .0 0 7 6 0 .5 7 3 0 0 .4 1 9 5 0 .9 3 8 9 0 .4 7 4 5 0 .5 7 7 8 0 .6 6 8 9 0 .6 4 1 8
RELAX2 - 0 .0 3 4 - 0 .8 5 6 0 .7 1 7 0 .4 3 0 - 0 .4 2 3 -0 .4 8 B 0 .5 8 8 0 .6 0 3
0 .9 4 8 4 0 .0 2 9 7 0 .1 0 8 8 0 .3 9 4 3 0 .4 0 3 6 0 .3 2 6 6 0 .2 1 9 9 0 .2 0 4 5
C0NFS2 - 0 .0 1 5 - 0 .5 0 8 0 .2 1 0 0 .0 6 8 - 0 .7 5 4 - 0 .7 8 6 0 .8 1 8 0 .1 7 9
0 .9 7 7 2 0 .3 0 3 2 0 .6 8 B 8 0 .8 9 7 3 0 .0 8 3 5 0 .0 6 3 6 0 .046B 0 .7 3 4 7
C0NFV2 - 0 .0 0 9 - 0 .4 8 8 0 .2 3 4 0 .1 1 1 - 0 .7 2 6 - 0 .7 5 8 0 .7 9 8 0 .2 1 4
0 .9 6 6 0 0 .3 2 5 5 0 .6 5 5 9 0 .8 3 4 6 0 .1 0 1 9 0 .0 8 0 5 0 .0 5 6 9 0 .6 8 3 8
STAI2 0 .0 9 7 0 .8 6 6 - 0 .4 4 1 - 0 .2 1 9 0 .7 2 2 0 .7 7 6 -0 .7 1 9 - 0 .2 5 5
0 .8 5 5 4 0 .0 2 5 6 0 .3 8 1 7 0 .6 7 6 0 0 .1 0 4 9 0 .0 6 9 7 0 .1 0 7 3 0 .6 2 5 1
EXPECT 0 .6 5 5 -0 .5 3 1 0 .4 3 3 0 .1 5 0 - 0 .7 5 8 - 0 .7 1 1 0 .5 6 4 0 .2 4 3
0 .1 5 8 2 0 .2 7 8 3 0 .3 9 1 0 0 .7 7 6 4 0 .0 8 0 6 0 .1 1 3 5 0 .2 4 3 3 0 .6 4 3 0
VAS12 -0 .4 7 7 0 .6 2 6 - 0 .1 8 3 0 .2 5 7 0 .9 8 5 0 .9 6 5 -0 .8 7 1 0 .0 0 8
0 .3 3 9 1 0 .1 8 3 3 0 .7 2 7 9 0 .6 2 3 3 0 .0 0 0 3 0 .0 0 1 8 0 .0 2 4 0 0 .9 8 7 3
VASA2 - 0 .4 7 3 0 .6 2 4 - 0 .2 0 0 0 .2 3 5 0 .9 8 3 0 .9 6 4 -0 .8 8 4 0 .0 2 0
0 .3 4 3 2 0 .1 8 5 2 0 .7 0 3 2 0 .6 5 4 3 0 .0 0 0 4 0 .0 0 1 9 0 .0 1 9 3 0 .9 6 9 7
TIME2 0 .3 4 8 - 0 .6 2 5 0 .2 2 8 - 0 .2 9 7 -0 .8 9 5 - 0 .9 0 7 0 .9 9 9 0 .1 3 9
0 .4 9 8 9 0 .1 6 4 4 0 .6 6 3 6 0 .5 6 7 8 0 .0 1 5 9 0 .0 1 2 5 0 .0 0 0 1 0 .7 9 3 1
group.
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BLUNT RELAX2 C0NFS2 C0NFV2
RELAX1 0 .9 2 8 - 0 .0 3 4 - 0 .0 1 5 -0 .0 0 9
0 .0 0 7 6 0 .9 4 8 4 0 .9 7 7 2 0 .9 8 6 0
STAI1 - 0 .2 9 3 - 0 .8 5 6 - 0 .5 0 8 - 0 .4 8 8
0 .5 7 3 0 0 .0 2 9 7 0 .3 0 3 2 0 .3 2 5 5
CONFSI 0 .4 0 9 0 .7 1 7 0 .2 1 0 0 .2 3 3
0 .4 1 9 5 0 .1 0 8 8 0.6BBB 0 .6 5 5 9
CONFV1 - 0 .0 4 1 0 .0 4 3 0 .0 6 8 0 .1 1 1
0 .9 3 8 9 0 .3 9 4 3 0 .8 9 7 3 0 .8 3 4 6
VASU - 0 .3 6 7 - 0 .4 2 3 -0 .7 5 4 - 0 .7 2 6
0 .4 7 4 5 0 .4 0 3 6 0 .0 8 3 5 0 .1 0 1 9
VASA1 - 0 .2 8 9 - 0 .4 8 7 - 0 .7 8 6 - 0 .7 5 8
0 .5 7 7 8 0 .3 2 2 6 0 .0 6 3 6 0 .0 8 0 5
TIMEI 0 .2 2 4 0 .5 8 8 0 .8 1 8 0 .7 9 8
0 .6 6 8 9 0 .2 1 9 9 0 .0 4 6 8 0 .0 5 6 9
MONT 0 .2 4 4 0 .6 0 3 0 .1 7 9 0 .2 1 4
0 .6 4 1 8 0 .2 0 5 4 0 .7 3 4 7 0 .6 8 3 8
BLUNT 1 .0 0 0 - 0 .0 5 8 - 0 .1 4 7 - 0 .1 5 2
0 .0 0 0 0 0 .9 1 2 6 0 .7 8 1 4 0 .7 7 3 8
RELAX2 - 0 .0 5 8 1 .0 0 0 0 .6 1 4 0 .6 1 3
0 .9 1 2 6 0 .0 0 0 0 0 .1 9 5 0 0 .1 9 5 8
C0NFS2 - 0 .1 4 7 0 .6 1 4 1 .0 0 0 0 .9 9 8
0 .7 8 1 4 0 .1 9 5 0 0 .0 0 0 0 0 .0 0 0 1
C0NFV2 - 0 .1 5 2 0 .6 1 3 0 .9 9 8 1 .0 0 0
0 .7 7 3 8 0 .1 9 5 8 0 .0 0 0 1 0 .0 0 0 0
STAU 0 .0 5 9 - 0 .8 6 7 - 0 .8 3 0 - 0 .8 1 8
0 .9 1 0 2 0 .0 2 5 3 0 .0 4 0 8 0 .0 4 6 5
EXPECT 0 .6 8 9 0 .2 7 4 0 .5 3 1 0 .5 3 0
0 .1 3 0 0 0 .5 9 9 4 0 .2 7 8 7 0 .2 7 9 1
VASU - 0 .4 8 5 - 0 .3 7 3 - 0 .7 2 4 - 0 .7 0 3
0 .3 2 9 5 0 .4 6 6 6 0 .1 0 3 4 0 .1 1 9 1
VASA2 - 0 .4 6 6 - 0 .3 9 3 -0 .7 5 1 - 0 .7 3 1
0 .3 5 1 2 0 .4 4 1 0 0 .0 8 5 3 0 .0 9 8 7
TIME2 0 .2 3 8 0 .5 6 6 0 .8 0 1 0 .7 8 0
0 .6 4 9 7 0 .2 4 1 6 0 .0 5 5 5 0 .0 6 7 0
STAU EXPECT VASU VASA2 TIME2
0 .0 9 7 0 .6 5 5 - 0 .4 7 7 - 0 .4 7 3 0 .3 4 B
0 .8 5 5 4 0 .1 5 8 2 0 .3 3 9 1 0 .3 4 3 2 0 .4 9 8 9
0 .8 6 6 - 0 .5 3 1 0 .6 2 6 0 .6 2 4 - 0 .6 2 5
0 .0 2 5 6 0 .27B 3 0 .1B 83 0 .1 8 5 2 0 .1 8 4 4
-0 .4 4 1 0 .4 3 3 - 0 .1 8 3 - 0 .2 0 0 0 .2 2 B
0 .3 8 1 7 0 .3 9 1 0 0 .7 2 7 9 0 .7 0 3 2 0 .6 6 3 6
- 0 .2 1 9 0 .1 5 0 0 .2 5 7 0 .2 3 5 - 0 .2 9 7
0 .6 7 6 0 0 .7 7 6 4 0 .6 2 3 3 0 .6 5 4 3 0 .5 6 7 8
0 .7 2 2 - 0 .7 5 8 0 .9 8 5 0 .9 8 3 - 0 .8 9 5
0 .1 0 4 9 0 .0 8 0 6 0 .0 0 0 3 0 .0 0 0 4 0 .0 1 5 9
0 .7 7 6 -0 .7 1 1 0 .9 6 5 0 .9 6 4 - 0 .9 0 7
0 .0 6 9 7 0 .1 1 3 5 0 .0 0 1 8 0 .0 0 1 9 0 .0 1 2 5
- 0 .7 1 9 0 .5 6 4 -0 .8 7 1 - 0 .8 8 4 0 .9 9 9
0 .1 0 7 3 0 .2 4 3 3 0 .0 2 4 0 0 .0 1 9 3 0 .0 0 0 1
- 0 .2 5 5 0 .2 4 3 0 .0 0 8 - 0 .0 2 0 0 .1 3 9
0 .6 2 5 1 0 .6 4 3 0 0 .9 8 7 3 0 .9 6 9 7 0 .7 9 3 1
0 .0 5 9 0 .6 8 9 - 0 .4 8 5 -0 .4 6 6 0 .2 3 8
0 .9 1 0 2 0 .1 3 0 0 0 .3 2 9 5 0 .3 5 1 2 0 .6 4 9 7
- 0 .8 6 7 0 .2 7 4 - 0 .3 7 3 -0 .3 9 3 0 .5 6 6
0 .0 2 5 3 0 .5 9 9 4 0 .4 6 6 6 0 .4 4 1 0 0 .2 4 1 6
- 0 .8 3 0 0 .5 3 1 - 0 .7 2 4 -0 .7 5 1 0 .8 0 1
0 .0 4 0 8 0 .2 7 8 7 0 .1 0 3 4 0 .0 8 5 3 0 .0 5 5 5
- 0 .8 1 8 0 .5 3 0 - 0 .7 0 3 -0 .7 3 1 0 .7 8 0
0 .0 4 6 5 0 .2 7 9 1 0 .1 1 9 1 0 .0 9 8 7 0 .0 6 7 0
1 .0 0 0 - 0 .5 0 9 0 .6 6 2 0 .6 7 5 - 0 .6 9 7
0 .0 0 0 0 0 .3 0 2 2 0 .1 5 1 9 0 .1 4 1 3 0 .1 2 3 4
- 0 .5 0 9 1 .0 0 0 - 0 .8 4 7 -0 .8 4 6 0 .5 5 8
0 .3 0 2 2 0 .0 0 0 0 0 .0 3 3 1 0 .0 3 3 7 0 .2 4 9 5
0 .6 6 2 - 0 .8 4 7 1 .0 0 0 0 .9 9 9 - 0 .8 7 1
0 .1 5 1 9 0 .0 3 3 1 0 .0 0 0 0 0 .0 0 0 1 0 .0 2 3 9
0 .6 7 5 - 0 .8 4 6 0 .9 9 9 1 .0 0 0 - 0 .8 8 4
0 .1 4 1 3 0 .0 3 3 7 0 .0 0 0 1 0 .0 0 0 0 0 .0 1 9 5
- 0 .6 9 7 0 .55B -0 .8 7 1 - 0 .8 8 4 1 .0 0 0
0 .1 2 3 4 0 .2 4 9 5 0 .0 2 3 9 0 .0 1 9 5 0 .0 0 0 0
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